Duke University
This Preliminary Offering Memorandum and the information contained herein are subject to completion or amendment without notice. Under no circumstances shall this Offering Memorandum constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, qualification or filing under the securities laws of any such jurisdiction. about October18,2016. and byMcGuireWoodsLLP,Raleigh,NorthCarolina, counseltotheUnderwriters. and RalphMcCaughan,Esquire,AssociateUniversity Counsel,Durham,NorthCarolina,counseltotheUniversity Charlotte, North Carolina, Bond Counsel to the University, by Sutherland Asbill & Brennan LLP, Atlanta, Georgia received bytheUnderwriters.Certainlegalmatters willbepasseduponbyRobinson,Bradshaw&Hinson,P.A., from registrationunderSection3(a)(4)oftheSecurities Actof1933,asamended. See “TAXTREATMENT”herein. or unsecured.See“TheSeries2016ABonds—SecurityProvisionsRelatingtotheBonds” herein. otherwise fromincurringadditionalindebtedness.Suchindebtedness,ifissued,maybeeither secured unsecured general obligations outstanding. Moreover, the University is not restricted by the Trust Agreement or See “TheSeries2016ABonds—Book-EntryOnlySystemandGlobalClearanceProcedures”herein. Series 2016ABondsshallmeanCede&Co.andnotthebeneficialownersof Bonds. is theregisteredowner of theSeries2016ABonds, references herein to theholdersorregisteredownersof herein) forsubsequentdisbursementtothebeneficialownersofSeries2016ABonds.SolongasCede &Co. will in turn remit such payments to Direct Participants (as defined herein) and Indirect Participants (as defined 2016A Bonds,paymentsofprincipalandinterestontheSeriesBondswillbemadetoCede&Co., which requested by an authorized representative of DTC. So long as Cede & Co. is the registered owner of the Series Co., asnomineeofTheDepositoryTrustCompany(“DTC”),NewYork,orsuchothername maybe When issued,theSeries2016ABondswillberegisteredunderaglobalbook-entrysysteminnameof Cede& made inbook-entryformonly,andindividualpurchaserswillnotreceivephysicaldeliveryofbondcertificates. denominations of$1,000oranywholemultiplethereof. described herein.See“TheSeries2016ABonds—Redemption”TheBondswillbeissued in and October1.TheSeries2016ABondsaresubjecttooptionalmandatoryredemptionpriormaturity as Series 2016ABonds. capital projectsoftheUniversityand(3)paycertainexpensesincurredinconnectionwithissuance certain outstandingtax-exemptbondsissuedforthebenefitofUniversity,(2)financeorrefinance trustee (the“BondTrustee”).TheUniversityintendstousetheproceedsofSeries2016ABonds(1)refund (the “Trust Agreement”) between the University and The Bank of New York Mellon Trust Company, N.A., as bond New Issue:Book-EntryOnly * Preliminary; subjectto change. October __,2016 ____%Series2016ABondsDueOctober1,2038 Dated: DateofDelivery It isexpectedthattheSeries 2016ABondswillbeavailablefordeliverythrough thefacilitiesofDTConor The Series2016ABondsareofferedsubjecttoprior sale,when,asandifissuedbytheUniversity The Series2016ABondshavenotbeenregisteredunder federalsecuritieslawsinrelianceuponanexemption Interest ontheSeries2016ABondsisnotexcludable fromgrossincomeforfederaltaxpurposes. The Series2016ABondsconstitutegeneralunsecuredobligationsoftheUniversity.Universityhasother The Series2016ABondsareissuableasfullyregisteredbonds.Purchasesofwill be Interest ontheSeries2016ABondsispayableApril1,2017,andsemiannuallythereaftereach1 The Series 2016A Bonds are being issued by Duke University (the “University”) pursuant to a Trust Agreement PRELIMINARY OFFERING MEMORANDUM DATED OCTOBER 5, 2016 B arclays ____% Series2016ABondsDueOctober1,2046
D u $530,115,000* k Taxable Bonds J.P. M Series 2016A e U ni organ v ersity M organ Price: ___% Price: ___% S Standard &Poor’s:AA+ (See “Ratings”herein) tanley Ratings: Moody’s:Aa1 CUSIP: ______CUSIP: ______
No dealer, broker, salesperson or other person has been authorized to give any information or to make any representation other than those contained in this Offering Memorandum in connection with the offering described herein, and, if given or made, such other information or representation must not be relied upon as having been authorized by the University or the Underwriters. This Offering Memorandum does not constitute an offer to sell or the solicitation of any offer to buy any securities other than the Series 2016A Bonds offered hereby, nor shall there be any offer or solicitation of such offer or sale of the Series 2016A Bonds in any jurisdiction in which it is unlawful for such person to make such offer, solicitation or sale.
The Underwriters have provided the following sentence for inclusion in this Offering Memorandum: The Underwriters have reviewed the information in this Offering Memorandum in accordance with, and as part of, their responsibilities under the federal securities laws as applied to the facts and circumstances of this transaction, but the Underwriters do not guarantee the accuracy or completeness of such information.
All quotations from and summaries and explanations of laws and documents herein do not purport to be complete, and reference is made to such laws and documents for full and complete statements of their provisions. Any statements made in this Offering Memorandum involving estimates or matters of opinion, whether or not expressly so stated, are intended merely as estimates or opinions and not as representations of fact. The information and expressions of opinion herein are subject to change without notice, and neither the delivery of this Offering Memorandum nor any sale of the Series 2016A Bonds shall under the circumstances create any implication that there has been no change in the affairs of the University since the date hereof.
This Offering Memorandum contains statements which, to the extent they are not recitations of historical fact, constitute “forward-looking statements”. In this regard, the words “may,” “will,” “plan,” “expect,” “estimate,” “budget,” “intend,” “project,” “forecast,” and similar expressions are intended to identify forward-looking statements. Such statements are based on the current expectations of the party making such statements as well as assumptions based on the information currently available to such party. A number of important factors, including factors affecting the University’s financial condition and factors which are otherwise unrelated thereto, could cause actual results to differ materially from those stated in such forward-looking statements. THE UNIVERSITY HAS NO OBLIGATION TO, AND DOES NOT PLAN TO, ISSUE ANY UPDATES OR REVISIONS TO THOSE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS, CONDITIONS OR CIRCUMSTANCES THAT OCCUR THAT DIFFER FROM THE EXPECTATIONS OR ASSUMPTIONS ON WHICH SUCH STATEMENTS ARE BASED.
Upon issuance, the Series 2016A Bonds will not be registered under the Securities Act of 1933, as amended, in reliance upon an exemption under Section 3(a)(4) of such act and the Trust Agreement has not been qualified under the Trust Indenture Act of 1939, as amended, in reliance upon an exemption under Section 304(a)(4) of such act. The Series 2016A Bonds will not be listed on any stock or other securities exchange.
IN CONNECTION WITH THIS OFFERING, THE UNDERWRITERS MAY OVER-ALLOT OR EFFECT TRANSACTIONS WHICH STABILIZE OR MAINTAIN THE MARKET PRICE OF THE SERIES 2016A BONDS AT A LEVEL ABOVE THAT WHICH MIGHT OTHERWISE PREVAIL IN THE OPEN MARKET. SUCH STABILIZING, IF COMMENCED, MAY BE DISCONTINUED AT ANY TIME.
INFORMATION CONCERNING OFFERING RESTRICTIONS IN CERTAIN JURISDICTIONS OUTSIDE THE UNITED STATES
REFERENCES HEREIN TO THE “ISSUER” MEAN DUKE UNIVERSITY AND REFERENCES TO “BONDS” OR “SECURITIES” MEAN THE SERIES 2016A BONDS OFFERED HEREBY. MINIMUM UNIT SALES
THE BONDS WILL TRADE AND SETTLE ON A UNIT BASIS (ONE UNIT EQUALING ONE BOND OF $1,000 PRINCIPAL AMOUNT). FOR ANY SALES MADE OUTSIDE THE UNITED STATES, THE MINIMUM PURCHASE AND TRADING AMOUNT IS 150 UNITS (BEING 150 BONDS IN AN AGGREGATE PRINCIPAL AMOUNT OF $150,000).
NOTICE TO INVESTORS IN THE EUROPEAN ECONOMIC AREA
THIS OFFERING MEMORANDUM IS NOT A PROSPECTUS FOR THE PURPOSES OF EUROPEAN COMMISSION REGULATION 809/2004 OR EUROPEAN COMMISSION DIRECTIVE 2003/71/EC (AS AMENDED, INCLUDING BY EUROPEAN COMMISSION DIRECTIVE 2010/73/EU, AS APPLICABLE) (THE “PROSPECTUS DIRECTIVE”). IT HAS BEEN PREPARED ON THE BASIS THAT ALL OFFERS OF THE SERIES 2016A BONDS WILL BE MADE PURSUANT TO AN EXEMPTION UNDER ARTICLE 3 OF THE PROSPECTUS DIRECTIVE, AS IMPLEMENTED IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA, FROM THE REQUIREMENT TO PRODUCE A PROSPECTUS FOR SUCH OFFERS. THIS OFFERING MEMORANDUM IS ONLY ADDRESSED TO AND DIRECTED AT PERSONS IN MEMBER STATES OF THE EUROPEAN ECONOMIC AREA WHO ARE “QUALIFIED INVESTORS” WITHIN THE MEANING OF ARTICLE 2(1)(E) OF THE PROSPECTUS DIRECTIVE AND ANY RELEVANT IMPLEMENTING MEASURE IN EACH MEMBER STATE OF THE EUROPEAN ECONOMIC AREA (“QUALIFIED INVESTORS”). THIS OFFERING MEMORANDUM MUST NOT BE ACTED ON OR RELIED ON IN ANY SUCH MEMBER STATE OF THE EUROPEAN ECONOMIC AREA BY PERSONS WHO ARE NOT QUALIFIED INVESTORS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS OFFERING MEMORANDUM RELATES IS AVAILABLE ONLY TO QUALIFIED INVESTORS IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA AND WILL NOT BE ENGAGED IN WITH ANY OTHER PERSONS.
NOTICE TO PROSPECTIVE INVESTORS IN THE UNITED KINGDOM
THIS OFFERING MEMORANDUM HAS NOT BEEN APPROVED FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (“FSMA”) AND DOES NOT CONSTITUTE AN OFFER TO THE PUBLIC IN ACCORDANCE WITH THE PROVISIONS OF SECTION 85 OF THE FSMA. IT IS FOR DISTRIBUTION ONLY TO, AND IS DIRECTED SOLELY AT, PERSONS WHO (I) ARE OUTSIDE THE UNITED KINGDOM, (II) ARE INVESTMENT PROFESSIONALS, AS SUCH TERM IS DEFINED IN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (THE “FINANCIAL PROMOTION ORDER”), (III) ARE PERSONS FALLING WITHIN ARTICLE 49(2)(A) TO (D) OF THE FINANCIAL PROMOTION ORDER, OR (IV) ARE PERSONS TO WHOM AN INVITATION OR INDUCEMENT TO ENGAGE IN INVESTMENT ACTIVITY (WITHIN THE MEANING OF SECTION 21 OF THE FSMA) IN CONNECTION WITH THE ISSUE OR SALE OF ANY SECURITIES MAY OTHERWISE BE LAWFULLY COMMUNICATED OR CAUSED TO BE COMMUNICATED (ALL SUCH PERSONS TOGETHER BEING REFERRED TO AS “RELEVANT PERSONS”). THIS OFFERING MEMORANDUM IS DIRECTED ONLY AT RELEVANT PERSONS AND MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS, INCLUDING IN CIRCUMSTANCES IN WHICH SECTION 21(1) OF THE FSMA APPLIES TO THE INSTITUTION. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS OFFERING MEMORANDUM RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. ANY PERSON WHO IS NOT A RELEVANT PERSON SHOULD NOT ACT OR RELY ON THIS OFFERING MEMORANDUM OR ANY OF ITS CONTENTS.
TABLE OF CONTENTS
INTRODUCTORY STATEMENT ...... 1
THE SERIES 2016A BONDS ...... 1
USE OF PROCEEDS ...... 4
ONGOING DISCLOSURE ...... 4
LITIGATION ...... 5
LEGAL MATTERS ...... 5
TAX TREATMENT ...... 5
ERISA AND CERTAIN RELATED CONSIDERATIONS ...... 11
FINANCIAL ADVISOR ...... 12
UNDERWRITING ...... 12
RATINGS ...... 13
FINANCIAL STATEMENTS ...... 13
CERTAIN RELATIONSHIPS ...... 13
OTHER MATTERS ...... 13
Appendix A—Certain Information Relating to Duke University ...... A-1 Appendix B—Duke University Financial Statements ...... B-1 Appendix C—Summary of Certain Documents ...... C-1 Appendix D—Book-Entry Only System and Global Clearance Procedures ...... D-1
i $530,115,000* Duke University Taxable Bonds Series 2016A
INTRODUCTORY STATEMENT
This Offering Memorandum, including the cover page and the appendices, is provided to furnish information regarding the $530,115,000* Duke University Taxable Bonds, Series 2016A (the “Series 2016A Bonds”) being issued by Duke University (the “University”) pursuant to a Trust Agreement dated as of October 1, 2016 (the “Trust Agreement”), between the University and The Bank of New York Mellon Trust Company, N.A., as bond trustee (the “Bond Trustee”). The Series 2016A Bonds are general unsecured obligations of the University. The University intends to use the proceeds of the Series 2016A Bonds to (1) refund certain outstanding tax-exempt bonds issued by the North Carolina Capital Facilities Finance Agency (the “Agency”) for the benefit of the University, (2) finance or refinance certain capital projects on the campus of the University and (3) pay certain expenses incurred in connection with the issuance of the Series 2016A Bonds.
The University also expects the Agency to issue approximately $319 million aggregate principal amount of its Revenue Refunding Bonds (Duke University Project) Series 2016B (the “Series 2016B Bonds”) in November 2016. The proceeds of the Series 2016B Bonds will be loaned to the University and used, together with other University resources, to refund certain outstanding tax-exempt bonds issued by the Agency for the benefit of the University. The obligation of the University under the loan agreement relating to the Series 2016B Bonds will be a general unsecured obligation of the University.
The University is a private, coeducational, not-for-profit institution of higher learning located primarily in Durham, North Carolina. For further information concerning the University, see Appendix A. Audited financial statements for the University for the fiscal years ended June 30, 2016 and 2015 are included herein as Appendix B.
Unless otherwise defined herein, capitalized terms used in this Offering Memorandum have the meanings ascribed to them in Appendix C under the heading “Definitions of Certain Terms.”
THE SERIES 2016A BONDS
Description
The Series 2016A Bonds will be dated the date of delivery. Interest on the Series 2016A Bonds will be payable on April 1, 2017, and semiannually thereafter on each April 1 and October 1 at the rates set forth on the cover page of this Offering Memorandum. The Series 2016A Bonds will mature, subject to the redemption provisions described below, on the dates set forth on the cover page of this Offering Memorandum.
The Series 2016A Bonds are issuable in fully registered form in denominations of $1,000 or any whole multiple thereof. Series 2016A Bonds in denominations of more than $1,000 may be redeemed in part from time to time in one or more units of $1,000. The Bank of New York Mellon Trust Company, N.A. will serve as Bond Trustee for the Series 2016A Bonds.
* Preliminary; subject to change.
1
Book-Entry Only System and Global Clearance Procedures
The Depository Trust Company (“DTC”), New York, New York, will act as securities depository for the Series 2016A Bonds. The Series 2016A Bonds will be issued as fully-registered securities registered in the name of Cede & Co. (DTC’s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One fully-registered Series 2016A Bond certificate will be issued for each maturity of the Series 2016A Bonds, each in the aggregate principal amount of the Series 2016A Bonds of such maturity, as set forth on the front cover hereof, and will be deposited with DTC. Beneficial interests in the Series 2016A Bonds may be held through DTC, Clearstream Banking, S.A. (“Clearstream Banking”) or Euroclear Bank S.A./N.V. (“Euroclear”) as operator of the Euroclear System, directly as a participant or indirectly through organizations that are participants in such system. Additional information about DTC and the Book-Entry System and Global Clearance Procedures is included herein in Appendix D.
Redemption
Optional Redemption. The Series 2016A Bonds are subject to redemption prior to their maturity at the option of the University, in whole or in part on any date, at a Redemption Price equal to the greater of:
(1) 100% of the principal amount of the Series 2016A Bonds to be redeemed; or
(2) the sum of the present value of the remaining scheduled payments of principal and interest to the maturity date of the Series 2016A Bonds to be redeemed, not including any portion of those payments of interest accrued and unpaid as of the date on which the Series 2016A Bonds are to be redeemed, discounted to the date on which the Series 2016A Bonds are to be redeemed on a semi-annual basis, assuming a 360-day year consisting of twelve 30-day months, at the Treasury Rate, plus __ basis points, plus, in each case, accrued interest on the Series 2016A Bonds to be redeemed to the redemption date.
“Treasury Rate” means, with respect to any redemption date for a particular Series 2016A Bond, the yield to maturity as of such redemption date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business Days prior to the redemption date (excluding inflation indexed securities) (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period from the redemption date to the maturity date of the Series 2016A Bond to be redeemed; provided, however, that if the period from the redemption date to such maturity date is less than one year, the weekly average yield on actually traded United States Treasury securities adjusted to a constant maturity of one year will be used.
At the request of the Bond Trustee to the University, the Redemption Price of the Series 2016A Bonds to be redeemed at the option of the University shall be determined by an independent accounting firm, investment banking firm or financial advisor retained by the University at the University’s expense to calculate such Redemption Price. The Trust Agreement provides that the Bond Trustee and the University may conclusively rely on the determination of such Redemption Price by such independent accounting firm, investment banking firm or financial advisor and shall not be liable for such reliance.
Mandatory Sinking Fund Redemption. The Series 2016A Bonds maturing on October 1, 20__ are subject to mandatory sinking fund redemption in part on October 1 of the following years and in the
2
following amounts at a Redemption Price equal to 100% of the principal amount of the Series 2016A Bonds being redeemed plus accrued interest to the redemption date:
Year Sinking Fund Requirement $ * *Maturity
The Series 2016A Bonds maturing on October 1, 20__ are subject to mandatory sinking fund redemption in part on October 1 of the following years and in the following amounts at a Redemption Price equal to 100% of the principal amount of the Series 2016A Bonds being redeemed plus accrued interest to the redemption date:
Year Sinking Fund Requirement $ * *Maturity
General Redemption Provisions. If less than all of the Series 2016A Bonds are to be redeemed, the particular maturities of Series 2016A Bonds to be redeemed at the option of the University will be determined by the University in its sole discretion.
If the Series 2016A Bonds are registered in book-entry only form and so long as DTC or a successor securities depository is the sole registered owner of such Series 2016A Bonds, if less than all of the Series 2016A Bonds of a maturity are called for prior redemption, the particular Series 2016A Bonds or portions thereof to be redeemed shall be allocated on a pro rata pass-through distribution of principal basis in accordance with DTC procedures, provided that, so long as the Series 2016A Bonds are held in book-entry form, the selection for redemption of such Series 2016A Bonds shall be made in accordance with the operational arrangements of DTC then in effect, and, if the DTC operational arrangements do not allow for redemption on a pro rata pass-through distribution of principal basis, the Series 2016A Bonds will be selected for redemption, in accordance with DTC procedures, by lot.
The University intends that redemption allocations made by DTC be made on a pro rata pass- through distribution of principal basis as described above. However, neither the University nor the Underwriters can provide any assurance that DTC, DTC’s direct and indirect participants or any other intermediary will allocate the redemption of Series 2016A Bonds on such basis.
In connection with any repayment of principal, including payments of scheduled mandatory sinking fund payments, the Bond Trustee will direct DTC to make a pass-through distribution of principal to the holders of the Series 2016A Bonds. For purposes of calculation of the “pro rata pass-through distribution of principal,” “pro rata” means, for any amount of principal to be paid, the application of a fraction to each denomination of the respective Series 2016A Bonds where (a) the numerator of such fraction is equal to the amount due to the respective bondholders on a payment date, and (b) the denominator of such fraction is equal to the total original par amount of the respective Series 2016A Bonds.
If the Series 2016A Bonds are no longer registered in book-entry only form, each owner will receive an amount of Series 2016A Bonds equal to the original face amount then beneficially held by that owner, registered in such investor’s name. Thereafter, any redemption of less than all of the Series 2016A Bonds of any maturity will continue to be paid to the registered owners of such Series 2016A Bonds on a pro-rata basis, based on the portion of the original face amount of any such Series 2016A Bonds to be redeemed.
3
Notice of redemption will be mailed (or sent by Electronic Means if so required or requested by a Holder) not less than thirty (30) or more than sixty (60) days prior to the redemption date to each registered owner of Series 2016A Bonds called for redemption at the address shown on the registration books. After notice has been given and funds for such redemption are on deposit with the Bond Trustee, interest on the Series 2016A Bonds so called for redemption will cease to accrue from and after the redemption date, such Series 2016A Bonds will cease to be entitled to any benefit or security under the Trust Agreement and the registered owners of such Series 2016A Bonds will have no rights in respect thereof except to receive payment of the Redemption Price and accrued interest to the redemption date.
In the case of an optional redemption, the redemption notice may state that (a) it is conditioned upon the deposit of moneys by the University, in an amount equal to the amount necessary to effect the redemption, with the Bond Trustee no later than the scheduled redemption date or (b) the University retains the right to rescind such notice on or prior to the scheduled redemption date (in either case, a “Conditional Redemption”), and such notice and optional redemption shall be of no effect if such moneys are not so deposited or if the notice is rescinded as described in the Trust Agreement. In the case of a Conditional Redemption subject to the deposit of moneys, the failure of the University to make funds available in part or in whole on or before the scheduled redemption date shall not constitute an Event of Default under the Trust Agreement and any Series 2016A Bonds subject to such Conditional Redemption shall remain Outstanding. Any Conditional Redemption subject to rescission may be rescinded in whole or in part at any time on or prior to the scheduled redemption date if a University Representative instructs the Bond Trustee in writing to rescind the redemption notice. Any Series 2016A Bonds subject to Conditional Redemption where redemption has been rescinded shall remain Outstanding, and the rescission shall not constitute an Event of Default under the Trust Agreement.
Security Provisions Relating to the Series 2016A Bonds
General. The Series 2016A Bonds are general unsecured obligations of the University. The University has other unsecured general obligations outstanding. Moreover, the University is not restricted by the Trust Agreement or otherwise from incurring additional indebtedness. Such additional indebtedness, if issued, may be either secured or unsecured and may be entitled to payment on parity with the Series 2016A Bonds.
Trust Agreement Funds and Accounts. The Trust Agreement establishes the Cost of Issuance Fund, the Bond Fund, in which there is established an Interest Account and a Sinking Fund Account, and the Redemption Fund. Each of these funds and accounts will be held by the Bond Trustee in trust and will be subject to a lien and charge in favor of the Holders of the Series 2016A Bonds until paid out or transferred as provided in the Trust Agreement. See “Appendix C — Summary of Certain Documents” herein.
USE OF PROCEEDS
The University intends to use the proceeds of the Series 2016A Bonds to (1) refund certain outstanding tax-exempt bonds issued by the Agency for the benefit of the University, (2) finance or refinance certain capital projects on the campus of the University and (3) pay certain expenses incurred in connection with the issuance of the Series 2016A Bonds.
ONGOING DISCLOSURE
In the Trust Agreement, the University agrees, by not later than six months after the end of each fiscal year of the University, beginning with the fiscal year ending June 30, 2017, to provide to the Bond Trustee and any Holder who requests the same in writing a copy of the audited financial statements of the University for such fiscal year. Except for providing such annual audited financial statements, the
4
University has not undertaken either to supplement or update the information included in this Offering Memorandum; however, the University has entered into continuing disclosure undertakings (the “Continuing Disclosure Undertakings”) in connection with tax-exempt revenue bonds issued for the benefit of the University (as shown in Note 10 to the Duke University Financial Statements attached as Appendix B). Holders and prospective purchasers may obtain copies of the information provided by the University under those Continuing Disclosure Undertakings from the Electronic Municipal Market Access system maintained by the Municipal Securities Rulemaking Board. Each Continuing Disclosure Undertaking terminates when the related tax-exempt revenue bonds are paid or deemed paid in full.
LITIGATION
There is no pending or threatened litigation seeking to restrain or enjoin the issuance, sale, execution or delivery of the Series 2016A Bonds, or in any way questioning or affecting the validity of the Series 2016A Bonds or any proceedings of the University taken with respect to the issuance or sale thereof, or in any way questioning or affecting the validity of the pledge or application of any money, revenues or security provided for the payment of the Series 2016A Bonds, the use of the Series 2016A Bond proceeds or the existence or powers of the University. There is no litigation pending or, to the knowledge of the University, threatened which could have a material adverse effect upon the business, operations or properties of the University. For a statement regarding pending litigation, see Appendix A “Certain Information Relating to Duke University — Litigation and Other Contingencies; Insurance.”
LEGAL MATTERS
Certain legal matters will be passed on for the University by Robinson, Bradshaw & Hinson, P.A., Charlotte, North Carolina, Bond Counsel to the University, and by Sutherland Asbill & Brennan LLP, Atlanta, Georgia, and Ralph McCaughan, Esquire, Associate University Counsel, Durham, North Carolina, and for the Underwriters by McGuireWoods LLP, Raleigh, North Carolina.
TAX TREATMENT
The following is a summary of certain U.S. federal income tax consequences relating to the purchase, ownership, and disposition of the Series 2016A Bonds. It does not provide a complete analysis of all potential tax considerations relating to the purchase, ownership and disposition of the Series 2016A Bonds.
This summary is based on the provisions of the Internal Revenue Code of 1986, as amended (the “Code”), the applicable Treasury Regulations promulgated or proposed under the Code (the “Treasury Regulations”), judicial authority, and administrative rulings and practice, all of which are subject to change, possibly retroactively, or to different interpretation.
This summary applies only to initial purchasers who acquire the Series 2016A Bonds at their original issue price within the meaning of Section 1273 of the Code and hold the Series 2016A Bonds as capital assets. A capital asset is generally an asset held for investment rather than as inventory or as property used in a trade or business. This summary does not discuss all of the aspects of U.S. federal income taxation that may be relevant to investors in light of their particular investment or other circumstances. It also does not discuss the particular tax consequences that might be relevant to investors who are subject to special rules under the federal income tax laws. Special rules apply, for example, to trusts; estates; tax-exempt investors; foreign investors; banks, thrifts, insurance companies, regulated investment companies, or other financial institutions or financial service companies; brokers or dealers in securities, commodities or foreign currency; U.S. persons who have a functional currency other than the U.S. dollar; partnerships or other flow-through entities; real estate investment trusts, financial asset securitization investment trusts, or
5
subchapter S corporations; persons subject to alternative minimum tax; persons who own the Series 2016A Bonds as part of a straddle, hedging transaction, constructive sale transaction or other risk-reduction transaction; persons who have ceased to be U.S. citizens or to be taxed as resident aliens; or persons who acquire the Series 2016A Bonds in connection with their employment or other performance of services.
This summary does not address all tax consequences. In particular, except as specifically described below, it does not discuss any estate, gift, generation skipping, transfer, state, local or foreign tax consequences. No ruling from the Internal Revenue Service (the “IRS”) has been sought with respect to the statements made and the conclusions reached in the following summary, and there is no assurance that the IRS will agree with those statements and conclusions. For all these reasons, each prospective investor should consult with its tax advisor about the federal income tax and other tax consequences of the acquisition, ownership, and disposition of the Series 2016A Bonds.
For purposes of this discussion, a “U.S. Holder” is a beneficial owner of the Series 2016A Bonds who is a “United States person” and whose status as a U.S. Holder is not overridden under the provisions of an applicable tax treaty. For these purposes, a “United States person” is a citizen or resident of the United States; a corporation or partnership that is created or organized in or under the laws of the United States or any of the fifty states or the District of Columbia, unless, in the case of a partnership, otherwise provided by the Treasury Regulations; an estate the income of which is subject to federal income taxation regardless of its source; or a trust if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust. For purposes of this discussion, a “Non-U.S. Holder” is a beneficial owner of a Series 2016A Bond that is neither a U.S. Holder nor an entity treated as a partnership for U.S. federal income tax purposes.
Tax Considerations Applicable to U.S. Holders
This section describes certain U.S. federal income tax consequences to U.S. Holders.
Interest. A U.S. Holder generally must include the stated interest on the Series 2016A Bonds in its gross income as ordinary interest income (1) when it is received, if the U.S. Holder uses the cash method of accounting for U.S. federal income tax purposes; or (2) when it accrues, if the U.S. Holder uses the accrual method of accounting for U.S. federal income tax purposes.
Original Issue Discount. Any Series 2016A Bond issued at an issue price less than its principal amount will have “original issue discount,” a portion of which will accrue as taxable income to the owner in each taxable year in addition to taxation of regular stated interest, regardless of whether the owner uses the cash or accrual method of accounting and regardless of the owner’s receiving no actual payment of the original issue discount until the maturity of the Series 2016A Bond. Taxation of original issue discount in this manner is subject to a de minimis exception based on the amount of the original issue discount in relation to the maturity of the Series 2016A Bond. Prospective investors should consult their tax advisors regarding the accrual of original issue discount and the effect of such accruals on the tax basis of their Series 2016A Bonds.
Market Discount. A U.S. Holder who acquires a Series 2016A Bond in a secondary market transaction at a price below the principal amount may be subject to federal income tax rules providing that accrued market discount will be subject to taxation as ordinary income on the sale or other disposition of a “market discount bond.” Dispositions subject to this rule include a redemption or retirement of a Series 2016A Bond. The market discount rules may also limit a holder’s deduction for interest expense for debt that is incurred or continued to purchase or carry a Series 2016A Bond. A market discount bond is defined generally as a debt obligation purchased subsequent to issuance, at a price that is less than the principal
6
amount of the obligation, subject to a de minimis rule. The Code allows a taxpayer to compute the accrual of market discount by using a ratable accrual method or a constant interest rate method. Also, a taxpayer may elect to include the accrued discount in gross income each year while holding the Series 2016A Bond, as an alternative to including the total accrued discount in gross income at the time of a disposition, in which case the tax basis of the Series 2016A Bond will be increased by the amount of discount included in gross income.
Bond Premium. A purchaser of a Series 2016A Bond who acquires it at a cost greater than the sum of all amounts payable on such Series 2016A Bond after the acquisition date (other than payments made at least annually over the term of such Series 2016A Bond of stated interest) will have amortizable bond premium. If the holder elects to amortize the bond premium, such election will apply to all Series 2016A Bonds held by the holder on the first day of the taxable year to which the election applies, and to all taxable bonds then held or thereafter acquired by the holder. The premium must be amortized using constant yield principles based on the purchaser’s yield to maturity. Amortizable bond premium is generally treated as an offset to interest income, and a reduction in basis is required for amortizable bond premium even though such premium is applied to reduce interest payments. Bond premium on a Series 2016A Bond held by a holder that has not elected to amortize bond premium will decrease the gain or increase the loss otherwise recognized on the disposition of the Series 2016A Bond. Purchasers who acquire Series 2016A Bonds at issue or in a secondary market transaction at a premium should consult with their own tax advisors with respect to the determination and treatment of such premium for income tax purposes.
Sale, Exchange, or Redemption of Series 2016A Bonds. A U.S. Holder generally will recognize gain or loss upon the sale, exchange, redemption, retirement, or other disposition of a Series 2016A Bond measured by the difference between (i) the amount of cash proceeds and the fair market value of any property received (except to the extent attributable to accrued interest income not previously included in income, which will generally be taxable as ordinary income, or attributable to accrued interest previously included in income, which amount may be received without generating further income), and (ii) the U.S. Holder’s adjusted tax basis in such Series 2016A Bond. A U.S. Holder’s adjusted tax basis in a Series 2016A Bond generally will equal its cost of the Series 2016A Bond, less any principal payments received by the U.S. Holder. Gain or loss on the disposition of Series 2016A Bonds will generally be a capital gain or loss (although any gain attributable to accrued market discount of the Series 2016A Bond not yet taken into income will be ordinary) and will be a long-term gain or loss if the Series 2016A Bonds have been held for more than one year at the time of disposition. The deductibility of capital losses is subject to limitations.
Defeasance. Defeasance of any Series 2016A Bond may result in a reissuance thereof, in which event a U.S. Holder will recognize taxable gain or loss equal to the difference between the amount realized from the deemed exchange (less any accrued qualified stated interest which will be taxable as such) and the U.S. Holder’s adjusted tax basis in the Series 2016A Bond.
Tax-Exempt Organizations. Income or gain from Series 2016A Bonds held by a tax-exempt organization will be subject to the tax on unrelated business taxable income if the Series 2016A Bonds are “debt-financed property” of the organization under Section 514(b) of the Code.
Unearned Income Tax. A U.S. Holder that is an individual or estate, or a trust that does not fall into a special class of trusts that is exempt from such tax, will be subject to a 3.8% tax on the lesser of (1) the holder’s “net investment income” for the relevant taxable year and (2) the excess of the holder’s adjusted gross income (increased by certain amounts of excluded foreign income) for the taxable year over a certain threshold (which in the case of individuals will be between $125,000 and $250,000, depending on the individual’s circumstances) (the “Unearned Income Tax”). A U.S. Holder’s net investment income will generally include its interest income and net gain from the disposition of the Series 2016A Bonds, unless such interest income and net gain is derived in the ordinary course of the conduct of a trade or business
7
(other than a trade or business that consists of certain passive or trading activities). Net investment income may, however, be reduced by properly allocable deductions to such income.
Information Reporting and Backup Withholding Tax. In general, information reporting requirements will apply to payments to certain noncorporate U.S. Holders of principal and interest on a Series 2016A Bond and the proceeds of the sale of a Series 2016A Bond. A U.S. Holder may be subject to backup withholding when it receives interest with respect to the Series 2016A Bonds or when it receives proceeds upon the sale, exchange, redemption, retirement, or other disposition of the Series 2016A Bonds. The backup withholding rate currently is 28%. In general, an investor can avoid this backup withholding by properly executing under penalties of perjury an IRS Form W-9 or substantially similar form that provides (1) such investor’s correct taxpayer identification number; and (2) a certification that such investor (a) is exempt from backup withholding because it is a corporation or comes within another enumerated exempt category, (b) has not been notified by the IRS that it is subject to backup withholding, or (c) has been notified by the IRS that it is no longer subject to backup withholding.
If an investor does not provide its correct taxpayer identification number on the IRS Form W-9 or substantially similar form, such investor may be subject to penalties imposed by the IRS. Backup withholding does not apply to payments made to certain holders, including corporations, tax-exempt organizations, and certain foreign persons, provided their exemptions from backup withholding are properly established. Amounts withheld are generally not an additional tax and may be refunded or credited against an investor’s federal income tax liability if such investor furnishes the required information to the IRS. The amount of any reportable payments for each calendar year and the amount of tax withheld, if any, with respect to those payments will be reported to the U.S. Holders of Series 2016A Bonds and to the IRS.
Tax Considerations Applicable to Non-U.S. Holders
This section describes certain U.S. federal income tax consequences to Non-U.S. Holders.
Payments of Interest. Subject to the discussion below on backup withholding and FATCA, interest paid on a Series 2016A Bond to a Non-U.S. Holder generally will not be subject to U.S. federal income tax, or withholding tax of 30% (or such lower rate specified by an applicable income tax treaty), provided that:
• such interest is not effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States;
• the Non-U.S. Holder is not a controlled foreign corporation related to the University through actual or constructive stock ownership;
• the Non-U.S. Holder is not actually or constructively a “10-percent” shareholder under Section 871(h) of the Code;
• the Non-U.S. Holder is not a bank receiving interest described in Section 881(c)(3)(A) of the Code; and
• either (1) the Non-U.S. Holder certifies in a statement provided to the applicable withholding agent under penalties of perjury on IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) that it is not a United States person and provides its name and address; (2) a securities clearing organization, bank or other financial institution that holds customers’ securities in the ordinary course of its trade or business and holds the Series 2016A Bond on behalf of the Non-U.S. Holder certifies to the applicable
8
withholding agent under penalties of perjury that it, or the financial institution between it and the Non-U.S. Holder, has received from the Non-U.S. Holder a statement under penalties of perjury that such holder is not a United States person and provides a copy of such statement to the applicable withholding agent; or (3) the Non-U.S. Holder holds its Series 2016A Bond directly through a “qualified intermediary” (within the meaning of applicable Treasury Regulations) and, in each case, certain other conditions are satisfied.
If a Non-U.S. Holder does not satisfy the requirements above, such Non-U.S. Holder may be entitled to a reduction in or an exemption from withholding on such interest as a result of an applicable tax treaty. To claim such entitlement, the Non-U.S. Holder must provide the applicable withholding agent with a properly executed IRS Form W-8BEN or W-8BEN-E (or other applicable documentation) claiming a reduction in or exemption from withholding tax under the benefit of an income tax treaty between the United States and the country in which the Non-U.S. Holder resides or is established.
If interest paid to a Non-U.S. Holder is effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non- U.S. Holder maintains a permanent establishment in the United States to which such interest is attributable), the Non-U.S. Holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption, the Non-U.S. Holder must furnish to the applicable withholding agent a valid IRS Form W- 8ECI, certifying that interest paid on a Series 2016A Bond is not subject to withholding tax because it is effectively connected with the conduct by the Non-U.S. Holder of a trade or business within the United States.
Any such effectively connected interest generally will be subject to U.S. federal income tax at the regular graduated rates. A Non-U.S. Holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected interest, as adjusted for certain items.
The certifications described above must be provided to the applicable withholding agent prior to the payment of interest and must be updated periodically. Non-U.S. Holders who do not timely provide the applicable withholding agent with the required certification, but that qualify for a reduced rate under an applicable income tax treaty, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. Non-U.S. Holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty.
Sale or Other Taxable Disposition. Subject to the discussion below on backup withholding and FATCA, a Non-U.S. Holder generally will not be subject to U.S. federal income tax on any gain realized upon the sale, exchange, redemption, retirement or other taxable disposition of a Series 2016A Bond (such amount excludes any amount allocable to accrued and unpaid interest, which generally will be treated as interest and may be subject to the rules discussed above in “—Tax Considerations Applicable to Non-U.S. Holders—Payments of Interest”) unless:
• the gain is effectively connected with the Non-U.S. Holder’s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the Non-U.S. Holder maintains a permanent establishment in the United States to which such gain is attributable); or
• the Non-U.S. Holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met.
9
Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular graduated rates. A Non-U.S. Holder that is a foreign corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.
Gain described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty), which may be offset by U.S. source capital losses of the Non-U.S. Holder (even though the individual is not considered a resident of the United States), provided the Non-U.S. Holder has timely filed U.S. federal income tax returns with respect to such losses.
Non-U.S. Holders should consult their tax advisors regarding any applicable income tax treaties that may provide different rules.
Information Reporting and Backup Withholding. Payments of interest to a Non-U.S. Holder generally will not be subject to backup withholding, provided the applicable withholding agent does not have actual knowledge or reason to know the holder is a United States person and the holder certifies its non-U.S. status as described above under “—Tax Considerations Applicable to Non-U.S. Holders— Payments of Interest.” However, information returns are required to be filed with the IRS in connection with any interest paid to the Non-U.S. Holder, regardless of whether any tax was actually withheld. In addition, proceeds of the sale or other taxable disposition of a Series 2016A Bond (including a retirement or redemption of the Series 2016A Bond) within the United States or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the statement described above and does not have actual knowledge or reason to know that such holder is a United States person or the holder otherwise establishes an exemption. Proceeds of a disposition of a Series 2016A Bond paid to a Non-U.S. Holder outside the United States and conducted through a non-U.S. office of a non-U.S. broker generally will not be subject to backup withholding or information reporting.
Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities of the country in which the Non-U.S. Holder resides or is established.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit against a Non-U.S. Holder’s U.S. federal income tax liability, provided the required information is timely furnished to the IRS.
FATCA Withholding. Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or “FATCA”) on certain types of payments made to non-U.S. financial institutions and certain other non-U.S. entities. Specifically, a 30% withholding tax may be imposed on payments of interest on, or gross proceeds from the sale or other disposition of, a Series 2016A Bond paid to a “foreign financial institution” or a “non- financial foreign entity” (each as defined in the Code), unless (1) the foreign financial institution undertakes certain diligence and reporting obligations, (2) the non-financial foreign entity either certifies it does not have any “substantial United States owners” (as defined in the Code) or furnishes identifying information regarding each substantial United States owner, or (3) the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution and is subject to the diligence and reporting requirements in (1) above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain “specified United States persons” or “United States-owned foreign entities” (each as defined in the Code), annually report certain information about such accounts, and
10
withhold 30% on certain payments to non-compliant foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.
Under the applicable Treasury Regulations and Notices, withholding under FATCA generally applies to payments of interest on a Series 2016A Bond and will apply to payments of gross proceeds from the sale or other disposition of a Series 2016A Bond on or after January 1, 2019.
Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in the Series 2016A Bonds.
ERISA AND CERTAIN RELATED CONSIDERATIONS
The following is a summary of certain considerations associated with the purchase of the Series 2016A Bonds by employee benefit plans that are subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), plans, individual retirement accounts and other arrangements that are subject to Section 4975 of the Code or provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of the Code or ERISA (collectively, “Similar Laws”), and entities whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement (each, a “Plan”).
General Fiduciary Matters
ERISA and the Code impose certain duties on persons who are fiduciaries of a Plan subject to Title I of ERISA or Section 4975 of the Code (an “ERISA Plan”) and prohibit certain transactions involving the assets of an ERISA Plan and its fiduciaries or other interested parties. Under ERISA and the Code, any person who exercises any discretionary authority or control over the administration of such an ERISA Plan or the management or disposition of the assets of such an ERISA Plan, or who renders investment advice for a fee or other compensation to such an ERISA Plan, is generally considered to be a fiduciary of the ERISA Plan.
In considering an investment in the Series 2016A Bonds of a portion of the assets of any Plan, a fiduciary should determine whether the investment is in accordance with the documents and instruments governing the Plan and the applicable provisions of ERISA, the Code or any Similar Law relating to a fiduciary’s duties to the Plan including, without limitation, the prudence, diversification, delegation of control and prohibited transaction provisions of ERISA, the Code and any other applicable Similar Laws.
Prohibited Transaction Issues
Section 406 of ERISA and Section 4975 of the Code prohibit ERISA Plans and other plans such as individual retirement accounts that are subject to Section 4975 but not Title I of ERISA, including entities whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement, from engaging in specified transactions involving plan assets with persons or entities who are “parties in interest,” within the meaning of ERISA, or “disqualified persons,” within the meaning of Section 4975 of the Code, unless an exemption is available. A party in interest or disqualified person who engaged in a non-exempt prohibited transaction may be subject to excise taxes and other penalties and liabilities under ERISA and the Code. In addition, the fiduciary of the ERISA Plan that engaged in such a non-exempt prohibited transaction may be subject to penalties and liabilities under ERISA and the Code. The acquisition and/or holding of Series 2016A Bonds by an ERISA Plan with respect to which the issuer or the underwriter is considered a party in interest or a disqualified person may constitute or result in a direct or indirect prohibited transaction under Section 406 of ERISA and/or Section 4975 of the Code, unless the investment
11
is acquired and is held in accordance with an applicable statutory, class or individual prohibited transaction exemption. In this regard, the U.S. Department of Labor has issued prohibited transaction class exemptions, or “PTCEs,” that may apply to the acquisition and holding of the Series 2016A Bonds. These class exemptions include, without limitation, PTCE 84-14 respecting transactions determined by independent qualified professional asset managers, PTCE 90-1 respecting insurance company pooled separate accounts, PTCE 91-38 respecting bank collective investment funds, PTCE 95-60 respecting life insurance company general accounts and PTCE 96-23 respecting transactions determined by in-house asset managers. In addition, Section 408(b)(17) of ERISA and Section 4975(d)(20) of the Code provide relief from the prohibited transaction provisions of ERISA and Section 4975 of the Code for certain transactions, provided that neither the issuer of the securities nor any of its affiliates (directly or indirectly) have or exercise any discretionary authority or control or render any investment advice with respect to the assets of any ERISA Plan involved in the transaction and provided further that the ERISA Plan pays no more than adequate consideration in connection with the transaction. There can be no assurance that all of the conditions of any such exemptions will be satisfied.
Because of the foregoing, the Series 2016A Bonds should not be acquired or held by any person investing “plan assets” of any Plan, unless such acquisition and holding will not constitute a non-exempt prohibited transaction under ERISA and the Code or a similar violation of any applicable Similar Laws.
Representation
Accordingly, by acceptance of a Series 2016A Bond, each purchaser and subsequent transferee of a Series 2016A Bond will be deemed to have represented and warranted that either (A) (i) no portion of the assets used by such purchaser or transferee to acquire or hold the Series 2016A Bonds constitutes assets of any Plan or (ii) the acquisition, holding and disposition of the Series 2016A Bonds by such purchaser or transferee will not constitute a non-exempt prohibited transaction under Section 406 of ERISA or Section 4975 of the Code or a similar violation under any applicable Similar Laws and (B) the purchaser will not transfer the Series 2016A Bonds to any person or entity, unless such person or entity could itself truthfully make the foregoing representations and covenants.
The foregoing discussion is general in nature and is not intended to be all inclusive. Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries, or other persons considering purchasing the Series 2016A Bonds on behalf of, or with the assets of, any Plan, consult with their counsel regarding the potential applicability of ERISA, Section 4975 of the Code and any Similar Laws to such investment and whether an exemption would be applicable to the purchase and holding of the Series 2016A Bonds.
FINANCIAL ADVISOR
Prager & Co., LLC (“Prager”) has been retained by the University to act as its financial advisor in connection with the issuance of the Series 2016A Bonds. Although Prager has assisted in the preparation of this Offering Memorandum, Prager is not obligated to undertake, and has not undertaken to make, any independent verification or to assume responsibility for the information contained in this Offering Memorandum.
UNDERWRITING
The Series 2016A Bonds are being purchased by J.P. Morgan Securities LLC (the “Representative”) on behalf of itself and Morgan Stanley & Co. LLC and Barclays Capital, Inc. (collectively, the “Underwriters”), at an aggregate purchase price of $______(representing the principal amount of the Series 2016A Bonds, less an underwriting discount of $______). The Contract
12
of Purchase between the Underwriters and the University provides that the Underwriters will purchase all of the Series 2016A Bonds, if any are purchased, and requires the University to indemnify the Underwriters against certain losses, claims, damages and liabilities. The initial public offering prices set forth on the cover page of this Offering Memorandum may be changed by the Underwriters and the Underwriters may offer and sell the Series 2016A Bonds to certain dealers (including dealers depositing Series 2016A Bonds into investment trusts) and others at prices lower than the offering prices set forth on the cover page hereof.
RATINGS
Moody’s Investors Service, Inc. has assigned a rating of “Aa1” to the Series 2016A Bonds and S&P Global Ratings, a business unit of Standard & Poor’s Financial Services LLC, has assigned a rating of “AA+” to the Series 2016A Bonds. Any explanation of the significance of each of such ratings may only be obtained from the rating agencies as follows: Moody’s Investors Service, Inc., 7 World Trade Center, 250 Greenwich Street, New York, New York 10007, and S&P Global Ratings, 55 Water Street, New York, New York 10041. There is no assurance that such ratings will remain in effect for any given period of time or that they may not be lowered, suspended or withdrawn entirely by either or both of the rating agencies. Any such downward change in or suspension or withdrawal of either or both of such ratings may have an adverse effect on the market price of the Series 2016A Bonds.
FINANCIAL STATEMENTS
The audited consolidated financial statements of the University as of June 30, 2016 and 2015, and for the years then ended, are included in Appendix B to this Offering Memorandum. The auditors have not been requested to consent to the inclusion of their report, which appears in Appendix B, and have not been engaged or requested to perform any procedures relating to this Offering Memorandum.
CERTAIN RELATIONSHIPS
Russell M. Robinson, II, an attorney with Robinson, Bradshaw & Hinson, P.A., bond counsel to the University, serves as a member of the Board of Trustees of The Duke Endowment, a nonprofit entity separate from the University, which provides an important source of support for the University. Robinson, Bradshaw & Hinson, P.A. has represented, is representing and may represent in the future the University in matters unrelated to the Series 2016A Bonds.
McGuireWoods LLP has represented and may represent in the future the University and Duke University Health System, Inc. in matters unrelated to the Series 2016A Bonds.
The Underwriters, the Financial Advisor and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for the University, for which they received or will receive customary fees and expenses. Robinson, Bradshaw & Hinson, P.A., Sutherland Asbill & Brennan LLP and McGuireWoods LLP have represented, continue to represent or expect to represent in the future the Underwriters and/or the Financial Advisor in unrelated matters.
OTHER MATTERS
Any statements herein involving matters of opinion, whether or not expressly so stated, are intended as such and not as representations of fact, and no representation is made that any of such statements will be realized. Neither this Offering Memorandum nor any statement which may have been made orally or in writing is to be construed as a contract with the owner of any Series 2016A Bonds.
13
The references herein to the Trust Agreement are brief outlines of certain provisions thereof. Such outlines do not purport to be complete, and for full and complete statements of such provisions reference is made to such Trust Agreement and other materials, copies of which will be on file at the office of the Bond Trustee in Jacksonville, Florida.
14 The University has duly authorized the execution and delivery of this Offering Memorandum.
DUKE UNIVERSITY
By: Executive Vice President
This page intentionally left blank.
-
Appendix A
Certain Information Relating to Duke University
APPENDIX A
CERTAIN INFORMATION RELATING TO DUKE UNIVERSITY
Table Of Contents
Page A- General ...... 1 Academic and Research Programs ...... 1 Faculty ...... 1 Students...... 2 Facilities and Properties ...... 2 Governance and Administration ...... 2 Board of Trustees ...... 2 Administration ...... 3 Duke University Affiliates ...... 4 Duke Management Company ...... 4 Duke University Health System, Inc...... 4 Selected University Financial Data...... 4 General ...... 4 Management’s Discussion and Analysis of Selected University Financial Data ...... 8 Tuition and Fees...... 8 Student Financial Aid ...... 8 Grants, Contracts and Similar Agreements ...... 8 Contributions ...... 9 Health System Support ...... 10 The Duke Endowment ...... 10 Investments ...... 10 Auxiliary Enterprises ...... 11 Facilities Investment Plan ...... 11 Indebtedness and Other Obligations ...... 11 Employees ...... 11 Benefit Plans ...... 12 Litigation and Other Contingencies; Insurance ...... 12
CERTAIN INFORMATION RELATING TO DUKE UNIVERSITY
General
Duke University (the “University” or “Duke”) is a private, coeducational, not-for-profit institution of higher education and research located primarily in Durham, North Carolina. The University traces its roots to the Union Institute, founded in 1838 and reorganized in 1851 as Normal College and in 1859 as Trinity College. James Buchanan Duke selected Trinity College to be the major recipient of his fortune when, in 1924, he provided endowment funds for the University, which now bears his family’s name (see Selected University Financial Data - The Duke Endowment below). The University is nonsectarian, but maintains a divinity school that receives a portion of its funding from the Board of Higher Education and Ordained Ministry of the United Methodist Church.
Academic and Research Programs
The University is fully accredited and internationally recognized. The University is organized around ten schools: the Trinity College of Arts and Sciences, the Pratt School of Engineering, the Fuqua School of Business Administration, the Divinity School, the Nicholas School of the Environment and Earth Sciences, the Law School, the School of Medicine, the School of Nursing, the Sanford School of Public Policy, and the Graduate School. Two schools, the Trinity College of Arts and Sciences and the Pratt School of Engineering, award undergraduate degrees. The graduate and professional schools provide advanced, specialized, academic, and professional training in a wide variety of fields.
Duke has long nurtured a tradition of interdisciplinary collaboration in teaching and research, facilitated by the scope and scale of the academic community and the physical proximity of the major schools and programs to each other on the Duke campus. Cross-disciplinary efforts at Duke include the Nicholas School of the Environment and Earth Sciences, the Institute of Genome Science and Policy, the Center for Nonlinear and Complex Systems, and the Center for Biologically Inspired Materials and Materials Science.
Faculty
For the 2016 fall semester, the faculty of the University consisted of 3,427 full time members, including 1,714 tenured and tenured track professors, and 1,713 non-tenured track. More than 97 percent of the faculty hold the highest academic degree in their field. The ratio of full-time students (excluding students completing dissertations) to full-time faculty members is 8 to 1.
A-1
Students
Enrollment for the 2015 fall semester consisted of 6,640 undergraduate and 9,339 graduate and professional school students. During the 2014-2015 academic year, the University conferred 1,841undergraduate degrees and 3,388 graduate and professional degrees. The following tables provide a summary of applications, acceptances, and matriculations for the five most recent academic years.
Undergraduate Students Academic Year Applications Acceptances Matriculants 2015-16 30,130 3,565 1,742 2014-15 31,523 3,596 1,721 2013-14 31,201 3,819 1,730 2012-13 30,385 4,075 1,714 2011-12 28,165 3,958 1,722 Graduate and Professional Students Academic Year Applications Acceptances Matriculants 2015-16 28,124 7,909 3,435 2014-15 28,733 7,945 3,347 2013-14 27,983 7,760 3,032 2012-13 32,476 7,295 3,051 2011-12 31,976 7,235 3,017
The University offers a wide variety of activities for its students, including over 400 organizations and clubs, 24 fraternities and 18 sororities, 16 student publications, 32 intramural sports and 37 club sports, 13 men’s varsity athletic teams and 13 women’s varsity athletic teams. The University is a member of the National Collegiate Athletic Association’s Atlantic Coast Conference.
Facilities and Properties
The University’s main campus consists of approximately 800 acres in Durham, North Carolina, including the West Campus with its distinctive Gothic architecture and famed Chapel, the Georgian-styled East Campus, and, between the two, the Central Campus. The University also owns 15 acres in Beaufort, North Carolina, home of the Duke University Marine Laboratory, 7,044 acres of forest land in the Piedmont area of North Carolina known as Duke Forest, and certain other properties inside and outside of North Carolina.
The principal facilities located on the main campus include numerous academic, research, residential and administrative buildings, along with gymnasiums, an indoor and an outdoor stadium, an indoor tennis facility, an art museum, student activities buildings, student recreational buildings, several arts performance spaces, and the Chapel.
The University continues to make on-going investments in capital facilities. See Facilities Investment Plan below.
Governance and Administration
Board of Trustees
The University is governed by a Board of Trustees (the “Trustees”) consisting of 37 members, including 36 drawn from private, public and community interests and the President of the University, who serves as a voting ex-officio member. In accordance with the University’s charter, 24 members are elected by the Trustees and 12 by graduates of the University. Nominees presented for election by graduates of the University in accordance with the University’s charter as set forth above are nominated by a majority of the Trustees in accordance with the bylaws of the University.
A-2
The Trustees’ responsibilities include the adoption of curricula for the constituent schools, approval of the University’s budget, including tuition and fee schedules, creation of new schools and departments, approval of investment and debt policies, and land use and development.
The Trustees conduct University business through nine permanent standing committees. The Executive Committee is empowered to act for the full Board of Trustees between scheduled meetings. The other eight committees, which exercise advisory powers only, are Academic Affairs; Audit, Risk and Compliance; Business and Finance; Facilities and Environment; Human Resources; Institutional Advancement; Medical Center Academic Affairs; and Undergraduate Education.
The Trustees are:
Mr. David M. Rubenstein, Chair Mr. Jack O. Bovender, Jr., Vice-Chair Ms. Robin A. Ferracone, Vice-Chair
Ms. Lisa Borders Dr. Michael Marsicano Dr. Richard H. Brodhead, ex officio Ms. Martha L. Monserrate Mr. Tim Cook Ms. Patricia R. Morton The Honorable Allyson Kay Duncan Mr. N. Shepard Moyle Mr. Ralph Eads, III Dr. Clarence G. Newsome Dr. Paul Farmer Mr. Stephen G. Pagliuca Mr. Xiqing Gao Ms. Ann Pelham Mr. Edward A. Gilhuly Mr. Robert R. Penn Dr. Thomas M. Gorrie Mr. Carmichael S. Roberts, Jr. Mr. Gerald L. Hassell Mr. Alan D. Schwartz Mr. William A. Hawkins, III Dr. Steven M. Scott Ms. Janet Hill Mr. Benjamin Shellhorn Ms. Betsy D. Holden Mr. Adam Silver Mr. Peter J. Kahn Ms. Laurene M. Sperling Dr. Elizabeth Kiss Rev. Ashley Crowder Stanley Ms. Anna E. Knight Mr. Jeffrey W. Ubben Mr. Neil Kondamuri Bishop Hope Morgan Ward
Administration
The Trustees elect the officers of the University, with the exception of the President of Duke Management Company. The President of Duke Management Company, who also serves as an officer of the University, is elected by the Board of Directors of that company and approved by the Trustees upon recommendation of the President of the University.
The principal academic, financial, and business officers of the University are:
Richard H. Brodhead President Sally Kornbluth Provost Tallman Trask III Executive Vice President Neal F. Triplett President, Duke Management Company A. Eugene Washington Chancellor for Health Affairs Richard V. Riddell Vice President and University Secretary Pamela J. Bernard Vice President and University Counsel Timothy Walsh Vice President and Treasurer Robert S. Shepard Vice President for Alumni Affairs and Development
President Richard H. Brodhead has announced he will step down on June 30, 2017, at the conclusion of his third term. The University is conducting a search for his successor.
A-3
Duke University Affiliates
Duke Management Company
DUMAC, Inc. (“DUMAC”), established in 1990, is a separate nonprofit support corporation responsible for managing the University’s investment assets. DUMAC allocates the investments across a number of domestic and international asset groups. Contracting with an array of external investment firms to manage discrete segments of the securities portfolios in accordance with objectives set by the DUMAC board, and consistent with policies established by the University’s Trustees, DUMAC oversees and monitors the performance of these investment managers for all the University’s investment pools, including the Non-Academic Retirement Plan.
An eleven-member Board of Directors, appointed by the Trustees, governs DUMAC. Membership is comprised of Trustees, University officers and others who are experienced investment or business professionals with close ties to the University. The DUMAC Board is charged with setting investment policies and objectives. Final approval of the investment policies and objectives rests with the University’s Trustees.
Effective July 1, 2007, DUMAC began managing the investment assets of The Duke Endowment (see below), in addition to the investment assets of Duke.
Duke University Health System, Inc.
Duke University Health System, Inc. (“DUHS,” and together with its consolidated affiliates, the “Health System”), a North Carolina nonprofit corporation organized and controlled by the University, operates an integrated academic health system which includes Duke University Hospital, an academic medical center; two community hospitals, Duke Regional Hospital and Duke Raleigh Hospital; ambulatory surgical centers; primary and specialty care clinics; home health care; hospice care; wellness centers; and community-based clinical practices. The Health System provides inpatient and outpatient facilities and financial support required for the conduct of internship and residency programs, clinical research, and other aspects of the academic mission of the Schools of Medicine and Nursing.
DUHS is a party to a Master Trust Indenture dated as of April 13, 1999 (the “Master Indenture”), originally among DUHS, Durham Therapies, Incorporated and The Bank of New York, as Master Trustee. DUHS is now the only member of the obligated group under the Master Indenture. The indebtedness issued under the Master Indenture is the obligation solely of DUHS; the University has no liability with respect to such indebtedness. At June 30, 2016, the aggregate principal amount of the outstanding Health System indebtedness was approximately $1.030 billion. The Master Indenture contains provisions limiting, among other things, the ability of DUHS to transfer and encumber property. Investors should not rely on the revenues or assets of the Health System for payment of the Series 2016A and 2016B Bonds.
Selected University Financial Data
General
The following Consolidated Condensed Balance Sheets as of June 30, 2012 through 2016, and Consolidated Condensed Statements of Activities for the fiscal years ended June 30, 2012 through 2016, were derived from the consolidated financial statements of the University. The Consolidated Condensed Balance Sheets and Consolidated Condensed Statements of Activities are summary only and should be read in conjunction with the audited consolidated financial statements of the University for the fiscal years ended June 30, 2016 and 2015, and related notes to such statements and accompanying information, which financial statements and accompanying information are included as Appendix B to the Official Statement (the “Financial Statements”).
A-4
DUKE UNIVERSITY CONSOLIDATED CONDENSED BALANCE SHEET (including the Health System)
As of June 30 (000’s Omitted) 2016 2015 2014* 2013 2012
Total assets $17,249,055 $17,357,843 $16,787,635 $15,536,933 $14,171,152
Total liabilities 5,263,538 4,361,626 4,223,375 4,101,275 4,367,787
Total net assets $11,985,517 $12,996,217 $12,564,260 $11,435,658 $9,803,365
Total net assets consists of: Unrestricted net $6,548,920 $7,300,720 $6,997,642 $6,561,317 $5,452,366 assets Temporarily 2,609,315 2,931,257 2,920,515 2,339,182 2,027,612 restricted net assets Permanently 2,827,282 2,764,240 2,646,103 2,535,159 2,323,387 restricted net assets
* 2014 shown is as restated in 2015
DUKE UNIVERSITY CONSOLIDATED CONDENSED STATEMENT OF ACTIVITIES (including the Health System)
Fiscal Year Ended June 30 (000’s Omitted) 2016 2015 2014* 2013 2012
Total operating revenues $5,663,275 $5,391,913 $4,882,600 $4,774,976 $4,611,924 and support
Total operating expenses 5,451,195 5,171,580 4,897,473 4,670,261 4,485,592
Excess (deficit) of 212,080 220,333 (14,873) 104,715 126,332 operating revenue over expenses
Change in net assets (1,222,780) 211,624 1,678,987 1,527,578 (634,315) from non-operating activities
Increase (decrease) in $(1,010,700) $431,957 $1,664,114 $1,632,293 $(507,983) net assets
* 2014 shown is as restated in 2015
A-5
The following Condensed Balance Sheet as of June 30, 2012 through 2016 and Condensed Statement of Activities for the fiscal years ending June 30, 2012 through 2016 include financial information for the University exclusive of the financial position and results of operations of the Health System.
DUKE UNIVERSITY CONDENSED BALANCE SHEET (excluding the Health System)
Fiscal Year Ended June 30 (000’s Omitted) 2016 2015 2014* 2013 2012
Total assets $12,594,506 $12,368,118 $11,964,711 $11,376,609 $10,201,760
Total liabilities 3,003,881 2,554,783 2,413,208 2,214,638 2,276,463
Total net assets $9,590,625 $9,813,335 $9,551,503 9,161,971 $7,925,297 Total net assets consists of: Unrestricted net assets $4,211,843 $4,175,151 $4.043,968 $4,334,577 $3,624,324 Temporarily restricted net assets 2,565,199 2,885,448 2,872,682 2,303,099 1,986,865 Permanently restricted net assets 2,813,583 2,752,736 2,634,853 2,524,295 2,314,108
* 2014 shown is as restated in 2015
A-6
DUKE UNIVERSITY CONDENSED STATEMENT OF ACTIVITIES (excluding the Health System) As of June 30 (000’s Omitted) 2016 2015 2014* 2013 2012 Unrestricted net assets activity Operating revenues: Tuition and fees (net of student $453,623 $429,043 $406,710 $390,275 $370,905 aid) Grants, contracts and similar 1,071,779 1,041,239 1,051,795 1,041,643 1,016,005 agreements Contributions 125,410 109,109 97,089 115,113 91,611 Investment return designated for 467,272 379,504 378,471 361,019 337,435 current operations Auxiliary enterprises 211,765 206,872 186,499 175,968 170,312 Academic support from DUHS 1 97,937 64,222 63,557 - - Other income 135,431 137,662 130,327 119,476 118,101 Net assets released from 57,116 51,907 46,488 41,486 37,839 restrictions Total operating revenues and 2,620,333 2,419,558 2,360,936 2,244,980 2,142,208 support Total operating expenses 2,563,236 2,461,630 2,382,538 2,303,346 2,248,353 Excess (deficit) of operating revenues over (under) operating 57,097 (42,072) (21,602) (58,366) (106,145) expenses Change in unrestricted net assets (530,405) 23,255 578,988 423,273 (295,571) from non-operating activities Transfer of net assets (to) from 510,000 150,0002 - 51,812 40,389 Health System Change in unrestricted net assets attributable to non-controlling interests 3 - - - 293,534 (35,070) Increase (decrease) in 36,692 131,183 557,386 710,253 (396,397) unrestricted net assets Increase (decrease) in temporarily restricted net (320,249) 12,766 569,583 316,234 (146,808) assets Increase (decrease) in permanently restricted net 60,847 117,883 110,558 210,187 100,318 assets
Total increase in total net $(222,710) $261,832 $1,237,527 $1,236,674 $(442,887) assets ______* 2014 shown is as restated in 2015. 1 In FY2015 and FY2014, academic support from DUHS was reclassified from non-operating to operating activities to more accurately reflect the use of funds. 2 During the fiscal year ended June 30, 2015, the Health System transferred $150 million to the University to establish a Chancellor’s Research and Development Augmentation fund. 3 Beginning in FY2015 and restated for FY2014, an accounting change resulted in the elimination in net assets attributable to non-controlling interest as detailed in footnote #5 of the FY2015 financial statements.
A-7
Management’s Discussion and Analysis of Selected University Financial Data
This discussion and analysis of selected University financial data excludes the financial position and results of operations of the Health System. All information set forth in the following discussion and analysis relates solely to the University, exclusive of the Health System, unless otherwise indicated.
Tuition and Fees
The University generates tuition and fees from both undergraduate and graduate students attending classes at the University. Tuition and fee revenue from undergraduate and graduate students prior to reduction for student financial aid increased by 5.0 percent during the fiscal year ended June 30, 2016, as compared to a 4.9 percent increase during the fiscal year ended June 30, 2015. In the fiscal year ended June 30, 2016, tuition and fee revenue prior to reduction for student financial aid provided approximately 28.0 percent of the University’s operating revenues, as compared to 28.9 percent for the fiscal year ended June 30, 2015.
Undergraduate Tuition and Required Fees per Student
For the Academic Year 2016-17 2015-16 2014-15 2013-14 2012-13 Tuition and Required Fees $51,265 $49,241 $47,243 $45,376 $43,623
Graduate tuition and required fees are set annually by the individual schools and subsequently approved by the Trustees. The tuition and required fees for graduate and professional schools range from $21,840 to $63,025 for the 2016-17 academic year.
Student Financial Aid
Student financial aid is the portion of student tuition, living expenses, and other costs covered by scholarships and fellowship grants from the University and is reported in the University’s Statement of Activities as a reduction to tuition and fees income. Student financial aid of $279.9 million and $269.2 million, respectively, was reported for the fiscal years ended June 30, 2016 and 2015. Students may also receive other student financial assistance in the form of jobs and student loans. Currently, five out of ten Duke undergraduate students receive student financial aid or other financial assistance from the University.
Grants, Contracts and Similar Agreements
The University is one of the world’s leading centers for research and training. Research and education programs receive significant support from grants and contracts awarded by governmental agencies and non-governmental organizations. Duke consistently ranks among the top research universities in the country as measured by federal funding. Grants, contracts, and similar agreements accounted for 41 percent of the University’s operating revenues for the fiscal year ended June 30, 2016, as compared to 43 percent for the fiscal year ended June 30, 2015. Approximately 52 percent of these revenues for the fiscal year ended June 30, 2016 were earned under contracts with the federal government and its departments and agencies. Revenue from government grants and contracts was $557 million, an amount substantially unchanged relative to the prior year. The following table summarizes the sources of grants, contracts, and similar agreements revenue for the past five fiscal years.
A-8
Sources Of Grants, Contracts, And Similar Agreements
Fiscal Year Ended June 30 (000’s Omitted) 2016 2015 2014 2013 2012
Federal Sources Dept. of Health and Human $404,323 $391,694 $408,815 $420,654 $438,857 Services Dept. of Defense 39,849 45,632 48,600 46,545 43,651 Dept. of Energy 11,085 8,164 8,085 9,440 8,974 National Science Foundation 42,457 44,832 42,738 47,801 44,096
Other Federal 25,585 31,731 33,627 26,229 20,218
Total Federal Sources 523,299 522,053 541,865 550,669 555,796
State and Other 34,038 35,435 35,340 33,694 32,511 Governmental Sources
The Private Diagnostic Clinic, 54,625 46,264 42,340 45,841 48,638 PLLC Other Non-Governmental 459,817 437,487 432,250 411,433 379,060 Sources Totals $1,071,779 $1,041,239 $1,051,795 $1,041,637 $1,016,005
The Private Diagnostic Clinic, PLLC (“PDC”) is a limited liability company consisting of physicians practicing in Duke affiliated entities. The PDC provides a structure in which members of the School of Medicine faculty engage in the private practice of medicine while serving as full-time faculty, conducting clinical teaching, and engaging in medical research.
Other Non-Governmental Sources include revenues from commercial and other non-governmental sponsors of research.
Contributions
The University derives significant financial support from The Duke Endowment (described below) and other contributors. The University received $328 million in charitable gifts during the fiscal year ended June 30, 2016, a 3.1 percent increase over the previous year. The continued growth in contributions is due to the generosity of alumni and friends participating in Duke’s ongoing comprehensive fundraising campaign, Duke Forward.
Unrestricted contributions received from private sources for both operational and capital development purposes, including discretionary grants from the Duke Endowment, totaled approximately $125.4 million for the fiscal year ended June 30, 2016, as compared with approximately $109.1 million and approximately $97.1 million for the fiscal years ended June 30, 2015 and 2014, respectively.
An important component of the University’s annual private philanthropic total is the portion given to the Duke Annual Fund. The Duke Annual Fund is an annual giving program that derives its support primarily from alumni and non-alumni parents. Donations to the Annual Fund are immediately expendable for current operating purposes. In the fiscal year ended June 30, 2016, gifts to the annual fund totaled approximately $37.5 million, compared with gifts of $36.3 million for the fiscal year ended June 30, 2015, representing an increase of approximately 3.3 percent.
A-9
Health System Support
In July 2016, the Health System transferred $510 million to the University’s School of Medicine. Of this amount, $310 million is intended to cover annual funding support for the School of Medicine for FY2017 through FY2026, with the remainder intended to establish a quasi-endowment for the School of Medicine.
The Duke Endowment
In 1924 James Buchanan Duke created The Duke Endowment as a charitable trust to serve the people of North Carolina and South Carolina by supporting selected programs of higher education, health care, children’s welfare, and spiritual life. In the trust indenture, Mr. Duke directed that funds immediately be made available for building a university around Trinity College which would reach and maintain “a place of real leadership in the educational world.” The trustees of Trinity College gratefully accepted the terms of the indenture and changed the name of the corporation to “Duke University” as a memorial to Mr. Duke’s father and the Duke family. Upon Mr. Duke’s death in 1925, substantial additional funds were contributed to The Duke Endowment as a bequest, including additional funds for the rebuilding of the old University campus and creation of a new campus.
The Duke Endowment’s indenture mandates a distribution to the University of a certain amount of income, subject to a limited right to withhold by The Duke Endowment’s trustees, which has never been exercised. The University is currently and has been for the past ten years a beneficiary of approximately 30 percent of The Duke Endowment’s income as the mandatory distribution. During the fiscal year ended June 30, 2016, the University received $12.5 million from The Duke Endowment as the mandatory distribution and another $31.4 million in discretionary grants.
While the University continues to receive substantial support from The Duke Endowment in the forms of operating income and discretionary grants, they are two separate entities, each with its own mission, officers, and trustees. A group of independent trustees controls the trust assets of The Duke Endowment. However, because the University derives unrestricted income from a portion of The Duke Endowment, subject to the limited right to withhold noted in the preceding paragraph, a portion of The Duke Endowment’s assets at market value is included in the University’s Balance Sheet. See the discussion of The Duke Endowment contained in Note 12 to the Financial Statements. At June 30, 2016, this portion was approximately $671.5 million.
Investments
During the fiscal year ended June 30, 2016 the University derived $467.2 million of its operating revenues from return on its investments. The following table summarizes the fair value of the University’s investments as of the end of the past five fiscal years:
As of June 30 (000’s Omitted) 2016 2015 2014 2013 2012 $8,129,791 $8,661,013 $8,376,965 $7,158,050 $7,059,144 Total Investments
Less: Permanently Restricted 1,870,579 1,762,725 1,663,584 1,635,448 1,563,643 Investments
Unrestricted and Temporarily $6,259,212 $6,898,288 $6,713,381 $5,522,602 $5,495,501 Restricted Investments
As of June 30, 2016, the University held investments with a fair value of approximately $8.1 billion; approximately $8.1 billion was invested in the Long Term Investment Pool (the “Pool”), an investment account actively managed by DUMAC for total return. The Pool’s assets are diversified among ten categories of investment types, such as domestic equity, real estate and fixed income. The University currently does not anticipate any major changes to its
A-10
investment policy. The Pool is the principal investment vehicle for the University’s permanently restricted assets, although reserve funds may also be invested in the Pool. University assets constituted 93.8 percent of the Pool at June 30, 2016; the remainder consisted of Health System assets. The Pool realized a 7.1 percent average annualized return for the ten fiscal years ended June 30, 2016, including a return of (2.6) percent for the fiscal year ended June 30, 2016.
The University adheres to a Trustee-approved spending policy for the Pool equal generally to 5.5 percent of the Pool’s average value over a rolling three-year period. Over time, this policy is designed to stabilize annual spending levels and preserve the real value of the investments. Expressed as a percentage of beginning market value, the effective spending rate for the fiscal year ended June 30, 2016 was 4.1 percent.
Auxiliary Enterprises
Income from auxiliary enterprises includes revenues from dining services, campus stores, housing and publications, among other areas.
Facilities Investment Plan
The University has a long-standing commitment to academic and financial planning and makes significant investments in its facilities for teaching, research, and related activities. The University funds this commitment through various sources including charitable contributions, the issuance of debt, and internal funds.
In May, 2016, the University had, in design or under construction, capital projects with an aggregate project cost of approximately $514 million. Of the aggregate project costs, the University expects to fund approximately $105.5 million from contributions, $99.8 million from existing University reserves, and $308.7 million from long-term debt including the 2016A Bonds, described in the following section. (See “The Plan of Financing” in the front portion of this Official Statement).
Indebtedness and Other Obligations
The University has outstanding a number of bond issues and other obligations. The University’s outstanding debt as of June 30, 2016 is described in Note 10 to the Financial Statements.
As of June 30, 2016, the total outstanding principal amount of long-term indebtedness of the University was approximately $1.698 billion. As of June 30, 2016, the University had issued and outstanding approximately $60.1 million principal amount of taxable commercial paper and approximately $33.9 million principal amount of tax- exempt commercial paper.
The University expects that on November 3, 2016, the North Carolina Capital Facilities Finance Agency will issue approximately $319 million of its Revenue Refunding Bonds (Duke University Project) Series 2016B, the proceeds of which will be loaned to the University. Approximately $247 million of Series 2009B Bonds will be refinanced with proceeds of the Series 2016A Bonds. Approximately $281.9 million of Series 2006A Bonds and $95.4 million of Series 2006B Bonds will be refinanced with the proceeds of the Series 2016B Bonds. After giving effect to the issuance of the Series 2016A Bonds and Series 2016B Bonds, the University will have approximately $1.946 billion outstanding principal amount of long-term indebtedness and approximately $94.0 million outstanding principal amount of taxable and tax-exempt commercial paper, with approximately $406 million of additional commercial paper authorized, but not issued.
Employees
Excluding the faculty, the University currently employs approximately 19,300 individuals. Three labor unions represent approximately 4 percent of these employees under collective bargaining agreements that expire in 2016 and 2017.
A-11
Benefit Plans
Faculty and exempt staff members of the University are eligible to participate in a defined contribution retirement plan. For fiscal years 2016 and 2015, the University contributed $141,308 and $135,366, respectively, to this plan. The University expects to contribute $146,106 to this plan in fiscal 2017.
The University has a non-contributory defined benefit pension plan for substantially all full-time non-exempt employees. The University expects to contribute $21,699 to the plan in fiscal 2017. At June 30, 2016 and 2015, the accumulated benefit obligation for the pension benefits was $1,860,740 and $1,467,942, respectively. At June 30, 2016, the plan was under funded in relation to accumulated benefits by $350,604. At June 30, 2015, the plan was over funded in relation to accumulated benefits by $128,565.
The University also sponsors an unfunded, defined benefit postretirement medical plan that covers all full-time employees who elect coverage and satisfy the plan’s eligibility requirements when they retire. The University pays all benefits under the medical plan on a current basis.
For information with respect to the plans, including certain assumptions used in the measurement of the University’s benefit obligation and benefit cost, see Note 8 to the financial statements attached to the Official Statement as Appendix B.
Litigation and Other Contingencies; Insurance
The University has incurred general liability losses in each of the last five years; however, the amounts of such losses have not been material, either individually or in the aggregate, in any such year. Although there are a number of such actions currently pending against the University, in the opinion of University Counsel, coverage under self- insured retention, existing and prior insurance programs, and provision for contingent liabilities when deemed appropriate by management, is adequate to protect the University against any potential liability arising from those actions that would have a material adverse effect on the University’s financial position.
If a final judgment were entered against the University in any general liability action in an amount in excess of its insurance coverage, the University would be liable for the excess.
A-12
Appendix B
Duke University Financial Statements
This page intentionally left blank.
- Financial Statements 2015/2016 HOLD FOR PHOTO
Financial Statements 2015/2016 Table of Contents
2 Letter from The Executive Vice President
3 Discussion of Financial Results for Fiscal Year 2016
10 Statistical Highlights
12 Independent Auditors’ Report
15 Consolidated Balance Sheets
16 Consolidated Statements of Activities
18 Consolidated Statements of Cash Flows
20 Notes to Consolidated Financial Statements
40 Schedule 1—University Balance Sheets (exclusive of DUHS) HOLD FOR PHOTO 41 Schedule 2—University Statements of Activities (exclusive of DUHS)
43 Schedule 3—University Statements of Cash Flows (exclusive of DUHS)
Duke University Financial Contacts Timothy W. Walsh Vice President of Finance and Treasurer Rachel L. Satterfield Associate Vice President for Finance and University Controller Elizabeth H. Carver Senior Director, Accounting and Reporting
The cover of this report features West Campus Union, which re-opened in August 2016 after a two-year renovation project.
Financial Statements 2015/2016 1 Letter from The Executive Vice President
Fiscal 2016 was a milestone year for Duke University, with a high Fiscal 2016 included positive operating results from both the level of capital investment, record philanthropic support from our University and Duke University Health System, Inc. (DUHS). DUHS alumni and other friends of the University, and strong operating delivered exceptional results, with an operating surplus of $303 results from both the University and Health System. million attributable to an increase in patient volumes. On July 1, Major capital renovations and new construction revitalized all corners 2016, DUHS transferred $510 million to the School of Medicine to of campus in fiscal 2016. A two-year project to completely recreate the provide predictable annual support to the School through 2036. These West Campus Union while maintaining the facility’s classic character funds are in addition to annual academic support DUHS provides to is nearing completion, and will return the Union to its prominence the School of Medicine for University-based medical faculty research as the center of student life at Duke. A renovation of Wallace Wade and education. Stadium is also nearly complete and will enhance the experience of Despite the fiscal 2016 performance described above, Duke’s students, faculty, and alumni through the modernization of the bowl consolidated net asset base declined $1 billion during the year, and concourse as well as the addition of a press and amenities tower reflecting the challenging investment and interest rate environment. and scoreboard. Our focus on enhancing the student experience will While Duke’s net asset base remains strong at $12 billion, the continue in the coming years, as we launch construction of new administration continues to recognize financial limitations that require undergraduate residence halls and renewal of some of our oldest tradeoffs and priority-setting in order to achieve our most important residences, and as we complete a new student health and wellness aspirations. This is particularly important given the imminent release center. of the University’s new academic strategic plan. Many of these investments were made possible by the generous Our continued success is dependent upon exceptional work by our support of our alumni and other friends of the University. In fiscal faculty, staff and students. We are thankful for their diligence and for 2016 alone, the University received over $500 million from our the continued support of our alumni and many other friends of Duke. donors, a record for Duke. The Duke Forward campaign, officially launched in fiscal 2013, crossed the $3.25 billion campaign goal a year ahead of schedule. We will continue to pursue support for our students, programs, and capital priorities through the conclusion of the campaign and beyond. Tallman Trask III Executive Vice President
2 Financial Statements 2015/2016 Discussion of Financial Results for Fiscal Year 2016
The Discussion of Financial Results (the Discussion) includes highly The following table summarizes the major components of net assets summarized data and should, therefore, be read in conjunction activity in fiscal 2016 and 2015: with the accompanying consolidated financial statements, notes, and supplementary schedules. All figures presented within the Summary of Changes in Consolidated Net Assets Discussion are consolidated and inclusive of Duke University (in millions) Health System, Inc. (DUHS) and referred to herein as Duke, unless specifically designated otherwise. 2016 2015 Operating results – University $ 57 $ (42) Net Assets Less: Operating support from DUHS (98) (64) Operating results – DUHS 253 326 Duke’s consolidated net asset base declined $1.0 billion in fiscal 2016 to $12.0 billion as of June 30, 2016, primarily due to a decline Nonoperating results: in the market value of Duke’s investments. The University’s Long- Investment return, net of spending (775) 58 Term Pool (LTP) investment portfolio experienced a total return of Restricted contributions, net of amounts negative 2.6%, while DUHS’ Health System Pool (HSP) experienced released from restrictions 151 162 a total return of negative 3.3%. The impact from investment Nonperiodic changes in defined performance was offset in part by strong operating performance benefit plans (514) (20) of both DUHS and the University, as well as philanthropic support (Losses) gains on interests in from the Duke Forward campaign. Over the past ten (10) years, perpetual trusts held by others (52) 22 despite the significant decline in fiscal 2009, consolidated net assets Other (32) (10) grew at a compound annual growth rate of 4% due primarily to investment returns, generous philanthropic support from our alumni Total (decrease) increase in and other donors, superior operating results of DUHS, and prudent consolidated net assets (1,010) 432 management of our internal resources. Total consolidated net assets $ 11,986 $ 12,996
Consolidated Net Assets ($ in billions) The operating results of the University and DUHS are detailed $14 13.0 independently later in the Discussion. Nonoperating activities of 12.6 12.0 Duke resulted in a net decline of $1.2 billion to the consolidated net $12 10.5 10.9 asset base and include: 10.0 9.9 9.4 M $10 Investment returns included in nonoperating activities reflect a total LTP investment loss of 2.6% (negative $381 million) and a return 8.0 9.6 9.8 9.6 7.5 of 4.4% ($419 million), for fiscal 2016 and 2015, respectively, less $8 8.6 8.3 8.3 amounts distributed for spending distributions of $394 million and 7.8 7.3 $361 million. Duke’s investment programs and related outcomes $6 6.4 6.1 are described in more detail within the “Investments/Endowments” $4 segment of this Discussion. 2.6 3.0 3.2 2.1 2.02.4 1.7 1.9 1.4 1.6 2.1 MRestricted contributions primarily received for endowment and $2 capital projects ($151 million). Restricted contributions are net of amounts released from restrictions of $57 million and $52 million $– for fiscal 2016 and 2015, respectively. 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 M Nonperiodic changes in defined benefit plans ($514 million Consolidated University DUHS decline) includes current year declines in the discount rates used to determine the valuations of Duke’s obligations related to the defined benefit pension and postretirement healthcare plans. M Losses from the University’s interests in perpetual trusts held by others, primarily The Duke Endowment ($52 million). University Operating Performance The operating results of the University, exclusive of DUHS, are presented in the supplemental Statements of Activities (Schedule 2 on page 40) following the notes to the consolidated financial statements.
Financial Statements 2015/2016 3 University operating activities for fiscal 2016 include all revenues MGrants and contracts revenue, which increased approximately 3% and expenses that support education and research efforts, as well as in fiscal 2016, represents the largest component of University other priorities of the University, and are discussed in more detail in revenue (41%), and is covered in detail within the “Sponsored their respective segments of this Discussion. Programs” segment of this Discussion. The fiscal 2016 operating results of the University improved $99 MNet tuition and fees reflect gross tuition and fees net of million compared to fiscal 2015, reflecting an 8.3% increase in student financial aid provided by the University. Gross tuition operating revenues partially offset by a 4.1% increase in operating and fees ($733 million) increased $35 million, or 5%, over expenses. the prior year, reflecting modest rate increases and enrollment Year-to-Year Change in University growth in certain programs. Student financial aid ($280 million) Operating Revenue and Expense (%) increased $11 million, or 4%, in fiscal 2016, reflecting the 10% 8.3% administration’s continued commitment to need-blind admission for undergraduates and strong financial support for graduate and professional students. 4.8% 4.1% 5% 3.4% 3.3% M Investment return designated for current operations, consisting of endowment spending distributions, returns on other invested 2.4% 2.3% 2.5% funds, and distributions from The Duke Endowment, increased 0% $88 million in fiscal 2016 and totaled $467 million. The changes in each component are covered in more detail within the “Investments/ -1.7% Endowments” segment of this Discussion. -5% Operating expenses for the University increased $102 million to $2.56 -8.4% billion in fiscal 2016. The major components of University operating expenses are summarized below: -10% 2012 2013 2014 2015 2016 FY 2016 University Operating Expenses – Operating Revenue Operating Expense $2.56 billion In response to the economic pressures first experienced in fiscal 2009, the administration has constrained operating expense growth Depreciation 8% in anticipation of limited growth in operating resources. Several Interest significant one-time transactions occurred in fiscal 2011, which 3% then drove correspondingly low comparative growth percentages Other operating in fiscal 2012. The fiscal 2016 operating revenue increase is due expenses to incremental support discussed in the Investments/Endowments 15% section of this discussion. The administration anticipates future growth patterns comparable to the fiscal 2015 and 2014 rates shown. Subrecipient Salaries Total operating revenues for the University increased $201 million payments and wages to $2.62 billion in fiscal 2016. The University’s major revenue 6% 47% components are summarized below: Rent and utilities 4% FY 2016 University Operating Revenues by Source – $2.62 billion Professional Services Net tuition and fees 5% Other 17% Employee benefits income 12% 9%
Auxiliary MSalaries and wages totaled $1.2 billion in fiscal 2016, a $40 million Government enterprises grants or 3% increase compared to fiscal 2015. This increase primarily 8% and contracts reflects fiscal 2016 merit-based salary increases for faculty and staff. 21% MEmployee benefits increased $18 million, or 6%, and remains Investment relatively consistent with fiscal 2015 as a percentage of salaries and return designated wages. for current operations MDepreciation expense of $200 million represented 8% of total operating 18% expenses in fiscal 2016, an increase of $7 million compared to the prior Private grants year. Fiscal 2016 capital activity is covered in detail within the “Capital Contributions and contracts Spending and Debt” segment of this Discussion. 7% 20%
4 Financial Statements 2015/2016 MOther operating expenses represented 15% of University operating DUHS operating expenses increased $162 million, or 6%, in expenses in fiscal 2016 and include various nonlabor expenses, most fiscal 2016 compared to the prior year. The significant increases notably supplies and materials, travel expenses and public relations. in 2016 were primarily in labor costs and medical supplies. Labor Other operating expenses remained virtually unchanged from the costs increased $76 million in fiscal 2016 due to a 4% increase prior year. in personnel, attributed primarily to volume growth, and planned increases in annual pay rates. The medical supplies increase includes DUHS Operating Performance a $47 million increase in drug expenses due to increased utilization. DUHS continues to provide care to patients who meet certain criteria As detailed in Note 1 to the consolidated financial statements, DUHS under its financial assistance policies without charge or at amounts operates as a controlled affiliate of the University, and manages all less than its established rates. Because DUHS does not pursue of Duke’s clinical health operations and facilities. The financial collection of amounts determined to qualify as charity care, they are results and financial position of DUHS are consolidated into the not reported as revenue or included in patient accounts receivable. financial statements of Duke under financial statement presentation In fiscal 2016, DUHS provided charity care with an estimated cost requirements governing colleges and universities. This differs from of $82 million, an increase of $12 million compared to fiscal 2015. financial statement presentation requirements governing health Total community benefit as defined by and reported to the Internal care organizations and used by DUHS in their separately issued Revenue Service was $242 million in fiscal 2016 and, combined financial statements. The fiscal 2016 net operating income of $303 with an additional $202 million of community investments, DUHS million reported in DUHS’ separately-issued consolidated statement provided $444 million of benefit to the community. This is an of operations represents a decline of $52 million compared to increase from $409 million in fiscal 2015, due primarily to the fiscal 2015’s record $355 million. increases in charity care and unreimbursed Medicaid. DUHS operating margins and positive cash flows from operating DUHS Operating Income and Cash Flow ($ in millions)1 activities over the last ten (10) years, combined with returns on its $600 invested reserves, allowed DUHS to make transfers to the University in support of the School of Medicine and other University functions 494 513 $500 of $1.2 billion during this time period. These transfers include a $510 million transfer recorded as a payable to the School of Medicine in June 2016. The planned $510 million transfer of cash and $400 321 investments was made to the School of Medicine on July 1, 2016, and 282 is comprised of the following two (2) components: (1) $310 million $300 to replenish the $280 million transfer made in June 2006, intended to 226 355 303 256 provide predictable annual support to the School of Medicine from $200 fiscal 2017 through fiscal 2026 and (2) $200 million to establish a 184 quasi-endowment fund that will provide support beyond July 1, 2026. $100 DUHS continued its history of providing annual operating support 96 for University-based medical faculty research and education with $– net transfers totaling $98 million to the School of Medicine in fiscal 2012 2013 2014 2015 2016 2016, also included in the $1.2 billion above total. Income from operations Cash flow from operations
Total DUHS operating revenue for fiscal 2016 increased $110 million, or 4% over the prior year. The increase in revenue was primarily driven by volume growth. Outpatient volume growth continues to outpace inpatient growth as more procedures transition to an outpatient setting, generally a less costly mode of care. Inpatient discharges and surgical cases increased 3% and 1%, respectively. Outpatient surgical cases increased 2%, outpatient endoscopy procedures increased 9%, and total outpatient visits, excluding surgeries and endoscopies, increased 6% over the prior year.
1 Certain components of nonoperating activities in the DUHS consolidated statement of operations and statements of cash flows are reclassified as operating items in Duke’s consolidated statements of activities and statements of cash flows in order to conform to financial statement presentation generally followed by colleges and universities. Losses on the extinguishment of debt and interest payments related to derivative swaps represent the primary components with $25 million and $15 million, respectively reclassified in fiscal 2016. Duke’s consolidated statements of activities and cash flows include $253 million of income and $507 million of cash flows, respectively, from operations related to DUHS for fiscal 2016. Financial Statements 2015/2016 5 Investments/Endowments As Duke’s investment base, including the endowment, has grown over the last ten (10) years, investment related support has become a larger Responsibility for managing Duke’s investment portfolio rests with contributor to the current operations of the University. Investment DUMAC, Inc. (DUMAC), a separate nonprofit support corporation returns supporting operations, which include endowment spending, organized and controlled by Duke. DUMAC invests Duke’s withdrawals from quasi-endowments, distributions from The Duke assets across domestic and international asset groups, principally Endowment, and income from invested working capital, grew from through investment advisory firms and partnerships. Growth of the $330 million in fiscal 2007 to $467 million in fiscal 2016. investment and endowment base is a critical factor in maintaining Duke’s financial strength and flexibility to meet current needs and fund future initiatives. Investment Return Supporting Current Operations ($ in millions – University Only) Duke’s investment portfolio primarily consists of debt, equity, and $500 other investments within the LTP and the HSP. $450 Duke’s investments have grown significantly over the last ten (10) $400 years and total approximately $10.9 billion as of June 30, 2016. Endowment and similar funds (including interests in perpetual trusts $350 held by others), representing approximately $6.8 billion of this total, $300 support the current and future operations of the schools, academic $250 departments, libraries and other facilities, and student financial aid. $200 $150 Growth of Investments and Endowment $100 (June 30 values, $ in billions) $50 $12 11.0 11.2 10.9 $– 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 $10 8.7 9.4 8.3 8.4 Endowment spending distributions Income from The Duke Endowment 7.9 7.8 $8 Other investment income 6.8 7.3 $6 7.0 6.8 To balance current and future needs, the University employs 5.9 6.1 5.7 5.6 6.0 investment and spending policies designed to provide an appropriate $4 4.8 4.4 flow of income to the operating budget while preserving the future purchasing power of the endowment assets in perpetuity. The LTP $2 spending rate is set by the administration and approved by the Board of Trustees. For fiscal 2016, the Board approved a 5% increase in $– spending rates for non-financial aid endowments and a 3% increase in 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 spending rates for financial aid endowments. The effective spending Investments Endowment rates for fiscal 2016 – based on June 30, 2015 investment market values – were 5.4% for financial aid endowments and 4.1% for non- DUHS accounts for $3.2 billion of Duke’s cash and investment financial aid endowments. The HSP is not subject to the University’s portfolio (prior to the $510 million transfer to the School of spending policies. Medicine), which primarily represents unrestricted working capital, In addition, the Board authorizes the use of supplemental endowment reinvested operating surpluses, and associated appreciation. distributions from quasi-endowments for special academic development initiatives and to support the operations and maintenance Fiscal Year Investment Returns of certain facilities. These supplemental distributions have grown from $31 million in fiscal 2007 to $125 million in fiscal 2016, due 2012 2013 2014 2015 2016 largely to two quasi-endowment funds established by transfers from LTP 1.0% 13.5% 20.1% 4.4% -2.6% DUHS to the School of Medicine in 2006 to provide annual academic support through 2016. In addition, the Board approved a $250 million HSP -0.1% 13.1% 19.7% 3.0% -3.3% liquidation from central unrestricted quasi-endowments that will occur over five years beginning in fiscal 2016. The University withdrew $25 For fiscal 2016, the LTP, in which 99% of the endowment (excluding million of the $250 million in fiscal 2016. perpetual trusts) is invested, returned negative 2.6%. DUMAC seeks Other investment income is another major component of investment to achieve an annualized real rate of return of at least 5.0%, net of fees, returns supporting current operations ($91 million in fiscal 2016). to fund the LTP spending rate and to allow growth of the endowment This income can vary significantly based on market returns and, as a after considering the effects of inflation. The total return on the HSP, result, has generated as much as $170 million of income in fiscal 2007 a more liquid fund managed for DUHS, was negative 3.3% in 2016. and as low as $54 million in fiscal 2013. Such support is generated
6 Financial Statements 2015/2016 through the corporate cash management strategies of Duke and is Total Grants, Contracts and Similar Agreements generally released under protocols approved by the Board of Trustees. ($ in millions) As planned, other investment income increased $30 million compared $1,200 to fiscal 2015, and primarily represents the fiscal 2016 liquidation of 1,072 1,016 1,042 1,052 1,041 invested working capital. The administration anticipates future income $1,000 levels consistent with fiscal 2016. $800 LTP Ten Year Annualized Investment Returns (%) 12.0% $600 10.6% 10.8% 9.9% 9.4% 10.0% $400
8.0% 7.1% $200 7.6% 7.5% 7.4% 7.2% 6.0% 6.8% $– 2012 2013 2014 2015 2016 4.0% Government Sources Private Sources Private Diagnostic Clinic
2.0% The slight decline in government sourced revenue shown above 0.0% is largely due to the tapering off of ARRA funding, with fiscal 2012 2013 2014 2015 2016 2016 support essentially consistent with that of fiscal 2015 at $557 10-Year Annualized Return 5.0% Real Rate of Return million. In addition to government sourced grants and contracts, Duke also As shown by the graph above, the LTP 10-year annualized returns received $460 million from private sources in fiscal 2016, an increase exceed the 5.0% target real return for each of the periods presented. of $22 million, or 5%, compared to fiscal 2015. This revenue consists Returns in excess of the real return target rate provide growth primarily of industry and private awards in support of clinical opportunities for university programs and priorities, while also research. The Duke Clinical Research Institute remains the world’s providing cushion against short-term market volatility and pressures. largest academic clinical research organization, generating almost 50% of Duke’s grant and contract revenue from private sources. Sponsored Programs Philanthropy The University conducts research in a collaborative interdisciplinary environment among its schools. The School of Medicine is one of the Contributions revenue reported within the consolidated financial largest biomedical research enterprises in the country with programs statements is calculated based on generally accepted accounting focused on the causes, prevention, and treatment of human disease. principles (GAAP). This differs from philanthropic support reported Campus-based schools under the Provost continue to increase their by Duke according to the guidelines established by the Council for research activity, primarily within Arts and Sciences, the Pratt School Advancement and Support of Education (CASE). CASE guidelines of Engineering, the Sanford School of Public Policy, and the Nicholas represent the philanthropy reporting standard for colleges and School of the Environment. universities, and is based on cash collections. The United States government is the largest source of grant and The generosity of alumni and friends in fiscal 2016 helped Duke contract funding for the University, with 38% of this support from remain at the forefront of academics, research, and patient care. Under the Department of Health and Human Services, Duke’s cognizant CASE guidelines, philanthropic cash receipts totaled $506 million in agency. The University’s government grant and contract funding has fiscal 2016, the highest annual giving year in Duke history. grown 7% since February 2009 when the United States Congress Fiscal 2013 was also Duke’s highest year for philanthropic support passed the American Recovery and Reinvestment Act (ARRA). on a GAAP-basis ($394 million), with the public announcement of Duke Forward, a comprehensive fundraising campaign, and several individually significant pledges. In fiscal 2016, Duke recorded $328 million in contributions revenue, including pledges, a $10 million or a 3% increase from fiscal 2015.
Financial Statements 2015/2016 7 As of June 30, 2016, the campaign has reached the $3.25 billion goal Capital Spending ($ in millions) – a year ahead of schedule. The University and its supporters will $500 continue to pursue support for our students, programs, and capital 457 priorities through the conclusion of Duke Forward on June 30, 2017 $450 and beyond. $400 $350 338 Contributions (GAAP-basis, $ in millions) 312 319 $300 276 $450 252 394 $250 $400 230 328 184 $350 $200 318 141 291 305 $150 $300 107 $100 $250 $200 $50 $– $150 2012 2013 2014 2015 2016 $100 DUHS3 University $50 $– Capital spending by the University in fiscal 2016 totaled $457 million, a 29% increase over fiscal 2015. 2012 2013 2014 2015 2016 Major capital activity in 2016 for the University included extensive Restricted for long term investment and capital projects renovations of the West Campus Union and Wallace Wade Stadium, as Unrestricted well as the new JB Duke Hotel, the new Student Health and Wellness For details on the goals and priorities of the campaign and more news Center, the new Scott Family Athletics Performance Center, the new on major gifts, visit http://dukeforward.duke.edu. Science Drive/Cameron Parking Garage, and a major expansion of venerable Cameron Indoor Stadium. A reconciliation of the CASE and GAAP totals is provided below (in millions): M The West Campus Union reopened in August 2016, after a comprehensive two-year renovation project that will reestablish Cash gifts per CASE (cash basis) $ 506 the prominence of the facility as the center of student life at Duke. Amounts included in grants and M The Wallace Wade Stadium renovation is nearing completion similar agreements (gifts per CASE) (139) and includes construction of a new 97,160 square-foot press and Grants and gifts from The Duke Endowment amenities tower, and modernization of the bowl and concourse. (gifts per CASE) (13) M The JB Duke Hotel will encompass the Thomas Executive 2 Net fiscal 2016 change in pledges (26) Conference Center and house Fuqua School of Business executive Total consolidated contributions students during their Durham-based programs. per GAAP statements $ 328 M The new Student Health and Wellness Center will consolidate student health services within one facility on West Campus. Additional information on GAAP reporting of contributions revenue M The Scott Family Athletics Performance Center will provide and contributions receivable is provided in Notes 2 and 4 of the administrative, training, and game-day functions serving student- consolidated financial statements, respectively. athletes participating in Duke’s Olympic sports, and well as retail space and event ticketing for Duke Athletics. Capital Spending and Debt M The Science Drive/Cameron Parking Garage will provide 2,400 Over the last decade, the University and DUHS have made significant new spaces in order to accommodate recent growth on West investments in land, buildings, and equipment. The University Campus, including the Athletic precinct. invested more than $1.2 billion over the last five years, impacting M The Cameron Indoor Stadium Expansion will provide new in excess of one million square feet of new or renovated living, hospitality and memorabilia space, as well as improve game-day teaching, and research space. DUHS, while owned and controlled functionality. by the University, operates under a different business model and has different budgetary considerations. DUHS has increased its net The University’s capital plan calls for $1.2 billion of additional investment in property and equipment by more than $1.2 billion spending over the next five (5) years, including major enhancements to since its creation in 1999. undergraduate student housing.
2 Includes changes to previously reported multi-year pledges, pledges receivable due to new multi-year commitments, and other fiscal 2016 adjustments. 3 DUHS capital spend amounts shown as reported in the separately issued DUHS consolidated financial statements.
8 Financial Statements 2015/2016 DUHS paused from an expansion level of capital spending in fiscal of the bond liability; therefore, neither the escrow nor the bonds are 2015 and 2016 following three (3) of the largest capital initiatives included in the consolidated balance sheets. The refunding resulted in ever undertaken at DUHS: the Duke Cancer Center (opened February a loss on extinguishment of debt of $25 million, which represents the 2012), the Duke Medicine Pavilion (opened July 2013), and the write-off of the unamortized bond issue costs and discount on bonds implementation of DUHS’ electronic health record system, Maestro payable and the escrow funding requirements for principal and interest Care (operational at all 3 hospitals, Duke Primary Care, and the payments in excess of the face value of the Series 2009A refunded bonds. Private Diagnostic Clinic by March 2014). For the five year period ended June 30, 2014, DUHS capital expenditures averaged $244 Looking Ahead million per year. Capital expenditures in fiscal 2016 and 2015 were $141 million and $107 million, respectively. DUHS plans to spend In fiscal 2017, the administration’s focus will remain on operating approximately $1.5 billion over the next five (5) years in order to meet effectively and efficiently in order to protect and advance Duke’s current strategic capital needs. financial health and commitment to our most important priorities. These Both the University and DUHS have issued various forms of debt as include: a primary source of capital project funding. Formal comprehensive M The imminent release of the new academic strategic plan and debt policies provide guidelines for the use of long-term financing, funding of related initiatives. commercial paper, and derivative transactions (in the form of interest M Continued focus on affordability of a Duke education, and rate and other swaps) in order to optimize the debt portfolios. supporting the University’s ongoing commitment to need-blind Effective and responsible debt portfolio management enables the admissions for undergraduates. University and DUHS to execute their strategic plans for facilities while preserving working capital. The University and DUHS hold M Completion of ongoing capital projects, including West Campus ratings of Aa1 and Aa2 with Moody’s and AA+ and AA with Standard Union, Wallace Wade Stadium, and the new Student Health and & Poor’s, respectively. Wellness Center, as well as construction of new undergraduate student residence halls and renovation of existing residences. Outstanding Debt ($ in billions) M Continued focus on the evolving approach to population health $2.4 models and the healthcare reimbursement environment including the health insurance exchange market, value-based reimbursement, and Medicare and Medicaid changes. $2.0 1.9 M Planning and execution of strategic capital projects to facilitate 1.6 1.6 $1.6 future clinical growth plans, including new inpatient bed towers 1.4 1.4 at Duke University Hospital and Duke Raleigh Hospital, a new psychiatry center on the Duke Regional Hospital campus, $1.2 and numerous planned projects in support of ambulatory and 1.1 1.1 1.1 1.1 1.1 outpatient facilities. $0.8 The administration will continue to proactively address financial and other challenges by operating with a strong sense of fiscal $0.4 responsibility and prudent decision making, while directing Duke’s resources to areas of highest priority and need. $– 2012 2013 2014 2015 2016
University Debt DUHS Debt4
In fiscal 2016, the University issued $545 million in Series 2015A and B bonds. The proceeds were used to refinance existing debt as well as to fund ongoing fiscal 2016 capital projects. In addition, DUHS issued $347 million in Series 2016A-C bonds. The proceeds ($384 million) were used to fund an escrow account that was irrevocably placed with a trustee to meet the principal and interest payments of the 2009A bonds ($180 million), as well as refund the 2005C bonds ($107 million) and a portion of the 2005B bonds ($73 million). The Series 2016A bonds were issued at a premium of $37 million. The refunding meets the legal requirements for defeasance
4 Excludes a $125 million capital lease for Duke Regional Hospital.
Financial Statements 2015/2016 9 Statistical Highlights
(dollars in thousands) 2016 2015 2014 2013 2012
Students: Undergraduate 6,379 6,401 6,390 6,393 6,383 Graduate and professional 8,135 8,100 7,927 7,860 7,977 Total fall enrollment 14,514 14,501 14,317 14,253 14,360 Degrees conferred: Baccalaureate 1,823 1,843 1,831 1,801 1,791 Masters 2,561 2,412 2,477 2,346 2,260 Doctorate 872 774 781 829 770 Total degrees conferred 5,256 5,029 5,089 4,976 4,821
Research: Grants, contracts and similar agreements: Federal government sources $ 504,715 $ 501,471 $ 522,953 $ 521,455 $ 538,232 Other government sources $ 53,030 $ 56,645 $ 54,834 $ 63,496 $ 50,781 Other $ 571,600 $ 538,693 $ 520,089 $ 505,795 $ 474,419 Total grants, contracts and similar agreements $ 1,129,345 $ 1,096,809 $ 1,097,876 $ 1,090,746 $ 1,063,432
Patient Care: Discharges 66,085 64,222 62,733 60,685 60,758 Patient days 390,561 384,584 371,650 354,631 348,456 Surgical and endoscopy cases 90,809 88,729 85,248 86,703 90,156 Outpatient visits 2,080,315 1,965,264 1,841,458 1,798,743 1,739,089 Emergency room visits 186,209 179,549 170,461 170,696 172,057
Endowment: Market value of endowment $ 6,839,780 $ 7,296,545 $ 7,036,776 $ 6,040,973 $ 5,555,196 Endowment funds per full-time equivalent student $ 471,254 $ 503,175 $ 491,498 $ 423,839 $ 386,852 Financial aid spending rate 5.4% 5.2% 5.9% 6.3% 5.9% Non-financial aid spending rate 4.1% 4.1% 4.4% 4.8% 4.6% Total LTP rate of return (2.6%) 4.4% 20.1% 13.5% 1.0%
Faculty and Staff: Tenured and tenure track 1,714 1,740 1,784 1,768 1,780 Non-tenure track 1,713 1,650 1,556 1,481 1,421 Total regular rank faculty 3,427 3,390 3,340 3,249 3,201 Staff 45,898 44,900 44,833 43,907 42,626 Total employees 49,325 48,290 48,173 47,156 45,827
10 Financial Statements 2015/2016 Gothic Reading Room located in Rubenstein Library KPMG LLP Suite 400 300 North Greene Street Greensboro, NC 27401
Independent Auditors’ Report
The Board of Trustees Duke University:
We have audited the accompanying consolidated financial statements of Duke University, which comprise the consolidated balance sheets as of June 30, 2016 and 2015, and the related consolidated statements of activities and cash flows for the years then ended, and the related notes to the consolidated financial statements.
Management’s Responsibility for the Financial Statements Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
Auditors’ Responsibility Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditors’ judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Duke University as of June 30, 2016 and 2015, and the changes in its net assets and its cash flows for the years then ended, in accordance with U.S. generally accepted accounting principles.
KPMG LLP is a Delaware limited liability partnership, the U.S. member firm of KPMG International Cooperative (“KPMG International”), a Swiss entity.